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Methyliminodiacetylhistidine dimethyl ester could not be synthesised.   However the 
other two ligands, glycine and glycyl-L-histidine were purchased and used for this study.      
The equilibrium constants of the ligand (glycyl-L-histidine) and the ligand complexes 
with Cu(II), Ni(II) and Zn(II) were investigated with glass electrode potentiometry and 
isothermal titration calorimetry at 25±0.01
o
C at an ionic strength 0.15M with NaCl.   
Potentiometric studies show that glycyl-L-histidine has three dissociable protons, and the 
neutral form of the ligand forms around pH 6.60.   Potentiometric results of copper(II) 
complexes with glycyl-L-histidine were compared to the potentiometric titration of the 
ligand with Ni(II) and Zn(II).   Copper(II) complexes of glycyl-L-histidine were more 
stable than Ni(II) and Zn(II) complexes of glycyl-L-histidine.   The potentiometric results 
for these systems were in good agreement with the literature results. 
 
From the potentiometric studies, the LH form of glycine was more stable than the LH 
form of glycyl-L-histidine by 1.19 log units.   The second protonation of glycyl-L-
histidine is on the imidazole ring and hence there is so comparable protonation site for 
glycine.   Instead the third protonation step of glycyl-L-histidine is comparable to the 
second protonation step of glycine.   The ML form of Cu(II)-glycyl-L-histidine 
complexes was more stable than that of Cu(II)-glycine complexes by 1.07 log units.   ML 
was the only common species for the two systems. 
 
The interaction between copper(II) and glycyl-L-histidine was also studied with 
isothermal titration calorimetry (ITC) from pH 5 to pH 8.   This was compared to a 
simpler system of glycine.   The change in speciation for this method was characterized 
by the N value.   The speciation from ITC results followed that of potentiometric results.   
The ML species of Cu(II) and glycine formed in acidic solutions, and the ML2 formed in 
basic solutions.   In this pH range, the ML species of Cu(II) and glycyl-L-histidine were 
the most predominant species in solution. 
The ITC results agreed with the potentiometric results.   At pH 5 where ML was the most 













system (N  1) Log K of the glycyl-L-histidine system was greater than that of the 
glycine system. 
 
The structures of the complexes were predicted with ultraviolet-visible (UV-Vis) 
spectrophotometry.   The visible spectra obtained for the different Cu(II)/Glycyl-L-
histidine species in solution were typical of Cu(II) complexes in a tetragonally distorted, 
octahedral environment.   The molar extinction coefficients are also typical of Cu(II) 
complexes and reflect the distortion of the metal-ion environment. 
 
The sequence of protonation/deprotonation of the ligand was studied with 
1
H NMR 
spectroscopy.   The first deprotonation of glycyl-L-histidine occurred at very acidic 
environments, and this was the deprotonation of the carboxylate proton.   The second 
deprotonation occurred at one of the imidazole nitrogens and the last one occurred in 
highly basic environments.   This was the deprotonation of the NH2 terminal.   The 
structure of complexes of Cu(II) with glycyl-L-histidine were also studied by 
1
H NMR.   
Form 
1
H NMR results, the active binding sites for glycyl-L-histidine are the imidazole 
nitrogens, the amide nitrogen and the terminal NH2 group.   The imidazole nitrogen 
involved in coordination first, followed by the amide nitrogen, followed by the terminal 
NH2 group 
 
The capacity with which the ligand can increase the low molecular weight Cu(II) 
complexes in blood plasma was studied using a computer model of blood plasma.  At 
reasonable concentrations, the ligand was not able to mobilise endogenous copper.     
Most of the ligand existed as LH and LH2 in blood plasma.   Moreover, glycyl-L-
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1.   INTRODUCTION 
1.1   RHEUMATIOD ARTHRITIS 
 
Rheumatoid arthritis, RA is an autoimmune disease that causes chronic inflammation of 
the joints [1, 2].  The body produces an antibody which is active against part of other 
antibodies, resulting in some changes in the synovial membranes [1, 3].    The cause of 
RA is not yet known, but the symptoms include morning stiffness, non specific joint 
pains, swelling and tenderness around inflamed joints, and loss of functioning and 
mobility of joints [1, 4]. 
 
Rheumatoid arthritis progresses in three stages [4, 5].   The first stage is the swelling of 
the synovial membrane, causing pain, warmth, stiffness, redness and swelling around the 
joint.    Second is the rapid growth and division of pannus, which causes the synovium 
fluid to thicken.    In the final stage, the inflamed cells release enzymes that may erode 
cartilage and bone, often causing the joint to lose its shape and alignment, resulting in 
more pain and loss of movement [5, 6]. 
 
Figure 1.1a and figure 1.1b show the cross-sectional structure of an affected joint and that 
of a normal joint respectively. 
 
 
 Figure 1.1a: cross-sectional view of a joint affected by RA 
 














Unlike in a normal healthy joint, the cartilage of a joint affected by RA gets eroded; the 
synovial membrane gets swollen and reddens [7]. 
 
In addition, Rheumatoid arthritis is said to be systemic because it can also cause 
inflammation of the tissue around the joints, as well as in other organs in the body such as 
eyes [8].   RA is common and it affects about 2% of the world population.   About 2.4 
million cases have been reported in USA [9, 10].   RA is more common in females.  The 
female/male ratio is 3:1, with the age group 35-55 being more prone to the condition.   
Everyone can have RA [11].    However, it is rare in rural black patients in South Africa, 
but the numbers increases with urbanization [12-14]. 
 
RA can be diagnosed by blood test for Rheumatoid factor, RF.    Rheumatoid factor is a 
group of auto-antibodies which may be present in the blood of people with Rheumatoid 
arthritis [15, 16].   The amount of Rheumatoid factor in the blood can be measured in two 
major methods [16-18]. 
i. Agglutination test: in this method, blood samples are mixed with tiny rubber 
(latex) beads that are covered with human antibodies.   If Rheumatoid factor is 
present the latex beads agglutinate together.   This method is best used as a first-
time screening test for Rheumatoid arthritis.  Another agglutination test mixes 
blood samples with a sheep’s red blood cells that have been covered with rabbit 
antibodies.   If the RF is present, the red blood cells clump together.   This method 
is often used to confirm the presence of RF [19]. 
 
ii. Nephelometry test: in this method, blood samples are mixed with antibodies that 
cause the blood to clump if RF is present.   A laser light is shone on the tube 
containing the mixture and the amount of light blocked by the blood samples is 
measured.   As the levels of RF increases, more clumping occurs, causing a 
cloudier sample and less light to pass through the tube [19, 20]. 
 
Rheumatoid factor is not only present in patients with Rheumatoid arthritis [21, 22].   It 












erythematosus (SLE).   Other conditions that may cause a positive RF test results include 
chronic hepatitis, sarcoidosis, chronic inflammation, various cancers, syphilis, infectious 
mononucleosis, parasites, liver disease and tuberculosis [23, 24]. 
 
Not all patients of Rheumatoid arthritis have a detectable Rheumatoid factor.   A more 
specific test is needed for such patients [24].   Anticitrullinated cyclic protein (anti-CCP) 
test measures the presence of an antibody associated with Rheumatoid arthritis.   The anti 
CCP test is gradually becoming more common.   Anti CCP test can reliably help to 
diagnose Rheumatoid arthritis in three different people [25]. 
i. Those with early-stage disease for whom uncertainty remains about diagnosis. 
ii. Those with mild conditions who test negative for RF, and 
iii. Those with critical conditions. 
 
1.2 THERAPY FOR RHEUMATOID ARTHRITIS 
 
There is no cure for the disease.   However for centuries the inflammation associated with 
this condition has been treated with copper rich diets such as crayfish, chocolates and 
peanuts
 
[26].   Copper bracelets were also worn with a conviction that sweat will 
transport copper from the bracelets to the binding sites where it is needed [27]. 
Pharmacological evidence suggests the use of copper complexes to be beneficial in 





Medication for the treatment of RA is used to 
1. Relieve or reduce pain, 
2. Improve daily joint function, 
3. Reduce joint inflammation, 
4. Prevent or delay significant joint damage, 
5. Prevent permanent joint damage, and 













Advanced means have been developed and these include the use of anti-inflammatory 
drugs, analgesia and steroids [30].   Surgical treatment in rheumatoid arthritis is used to 
relieve severe pain and improve function of severely deformed joints that do not respond 
to medication and physical therapy.  Total joint replacement (arthroplasty) can be done 
for many different joints in the body. Its success varies depending on which joint is 
replaced [31]. 
 
1.2.1 Non-steroidal Anti-inflammatory drugs 
  
The non-steroidal anti-inflammatory drugs (NSAIDs) are used to relieve pain.   The 
mechanism through which they work NSAIDs reduce pain is by blocking 
cyclooxygenase (COX) [31-35].    This enzyme exists in two isoenzymatic forms, 
cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2). Cyclooxygenase-1 induces 
the production of prostaglandins by the cells of the body and has several important 
functions. They encourage inflammation, pain, and fever; support the blood clotting 
function of platelets; and protect the lining of the stomach from the damaging effects of 
acid [35, 36].   Cyclooxygenase-2 activity is stimulated by proinflammatory cytokines 
and produces prostaglandins that arbitrate the inflammatory response and pain signaling 
transmission [36, 37]. 
 
However, NSAIDs can only be used for mild to moderate conditions and they are 
associated with some serious side effects [38].   The frequency of the side effects varies 
among NSAIDs [38, 39].   Nausea, decreased appetite, vomiting, diarrhea, constipation, 
rash, dizziness, drowsiness and headache are the most common side effects.   Prolonged 
and excessive use of NSAIDs may lead to even more serious side effects like 
gastrointesinal bleeding, renal impairment and toxicity due to inhibition of prostaglandin 
production, kidney failure and liver failure [40]. 
 
Examples of nonsteroidal anti-inflammatory are aspirin, ibuprofen, indomethacin, 













1.2.2 Disease modifying anti-rheumatic drugs (DMARDs) 
 
These are used to reduce the progression of the disease and sometimes to prevent joint 
damage [42].   The mechanism through which they work is not fully understood but it is 
believed that DMARDs work to ―suppress the body's overactive immune and/or 
inflammatory systems.‖ [43]   The DMARDs can be used at an earlier stage of the 
disease.   Examples of DMARDs are azathioprine, hydroxychloroquine, methotrexate, 
sulfasazine, etanercept, infliximab, leflunomide and gold salts [44, 45]. 
 
Disease modifying anti-rheumatic drugs also have side effects.   They can cause 
myelosuppression, renal or liver toxicity, skin rash or gastrointestinal disturbances [46]. 
 
1.2.3 Corticosteroids (Glucocorticoids) 
 
Corticosteroids reduce inflammation, attendant swelling and pain.   This is achieved by 
suppressing the immune system. [47, 48]   Corticosteroids have a higher potency than the 
NSAIDs and DMARDs but they have terrible side effects too.  Examples of 
corticosteroids are predonisone and metgylprenisolone [49]. 
 
Since they are strong medicines, the corticosteroids can lower the resistance of the 
immune system to infections [50].   Moreover, if taken for prolonged periods of time, the 
corticosteroids can cause glaucoma, gastrointestinal bleeding, diabetic metabolism, 
edemas, pancreatitis, aseptic bone necrosis, osteoporosis, myopathies, obesity, 
hypertension, sleep disturbances, psychiatric syndromes, delayed wound healing, 


















1.3 COPPER(II) AND RHEUMATOID ARTHRITIS 
 
Several reports show that copper(II) salts and organic complexes can increase anti-
inflammatory activity in vivo or they can strengthen the body’s natural inflammatory 
processes [52-56].    The exact mechanism by which this is achieved is not fully 
understood but there are several possibilities: 
 
1. Cu(II) may modify the production of prostaglandins by the body cells.   Reduced 
amounts of prostaglandins  may reduce inflammation since they(prostaglandins)  
encourage inflammation and pain, 
 
2. It may stimulate the production of lysyl oxidase or it may modify the activity of 
lysyl oxidase which is a copper-containing enzyme liable for the protection of 
collagen and elastin in tissues.    Increased amounts of lysyl oxidase may reduce 
the destruction of tissues, especially the cartilage tissue inpatients with 
rheumatoid arthritis. 
 
3. It may enhance the activity of histamine.   Histamine regulates the inflammation 
response. 
  
4. It may induce the production of superoxide dismutase or activity of superoxide 
dismutase.   Superoxide Dismutase (SOD) is an enzyme that repairs cells and 




5. Cu(II) may improve  lysosomal membranes.   The lysosomes are acidic enzymes 
that may destroy the synovial membrane.  Improved lysosomal membrane may 
















1.4  AIM  
 
The main aim of this study was to develop a novel copper based anti-inflammatory drug 
that will reduce inflammation associated with rheumatoid arthritis.   The drug (ligand) 
should have the following features; 
i. It should be more selective to Cu(II) than most bivalent cations especially Ca(II) 
and Zn(II) which are found in large concentrations in blood plasma. 
ii. It must form strong and kinetically labile complexes with Cu(II) in order to 
transport and release Cu(II) at the biological sites where it is needed. 
 
iii. It should form bioavailable copper(II) complexes.   This means that the complex 
should be lipophilic and hence neutral (uncharged) and form thermodynamically 
stable complexes with Cu(II).    
 
iv. The ligand that promotes dermal absorption of Cu(II) is desired so that it will 





1. Design of the new ligand which meets the criteria above. 
2. Synthesis and characterization of the ligand 
3. Measure thermodynamic data for the complexes using; 
a) Glass electrode potentiometry, 
b) Isothermal titration calorimetry, 
4. investigating the structure using; 
a) UV-Vis spectrophotometry, and 
b) 1H NMR 
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2.DESIGN AND SYNTHESIS OF THE LIGAND 
2.1 INTRODUCTION 
 
Previous studies show that high protein diets increase the absorption of Cu(II) [1, 2].   
The Cu(II) transport site for albumin protein is one of the most extensively studied 

















The copper(II) binding site in human serum albumin involves the -NH2 nitrogen, two 
peptide nitrogens and an imidazole nitrogen of the N-terminal Asp-Ala-His residue [3].    
Human serum albumin is more specific to Cu(II) than most proteins [4. 5].    This makes 
Cu(II) less bioavailable when complexed with HSA than when complexed with other 
protein molecules [5].  However, additional histidine encourages uptake of Cu(II) [4, 5].   
This is related to the histidine residue of the HSA [4].   Studies suggest the cell 
recognizes and most probably binds with the Cu(II)-albumin complexes but not 

















2.2 PRINCIPLES OF DESIGN OF THE DRUG (LIGAND) 
 
The designed ligand has donor nitrogen atoms.   Nitrogen atoms are said to be more 
selective for Cu(II) than most bivalent cations [6, 7], especially Ca(II) and Zn(II) which 
are found in large concentrations in blood plasma [8].   Moreover, the designed ligand 
has two amide nitrogens.   Since coordination to the amide nitrogens results in their 
deprotonation, the complex of copper(II) and would be formally neutral  [9, 10].    The 













In addition, a ligand that promotes dermal absorption of Cu(II) is desired.   For dermal 
absorption the complex cannot be too lipophilic or it will become trapped in the dermus, 
however, it cannot be too hydrophilic or it will not penetrate the dermus.  The designed 
ligand has two glycyl residues and two histidine residues.   The ligand is therefore 
believed to be both lipophilic and hydrophilic [9, 10]. 
 
Moreover, the ligand that forms stable complexes with Cu(II) is required.   The ligand 
should also form kinetically labile complexes in order to transport and release Cu(II) at 
the biological sites where it is needed [11].   The stability of the ligand depends on the 
number of donor atoms, the number of chelate rings, the size of the rings, the number of 
bonds between the central metal ion and the ligand, and the number of ligands around the 













Figure 2.2: The designed ligand (the letters in purple font are  




















the stability of complexes.   The designed ligand is expected to form a 5,4,5; 5,5,5 
chelating system.  Of course not all 5 donor atoms will be in a plane but rather a 
tetragonally distorted octahedral complex is expected.   The vacant site will be occupied 











The ligand has several binding sites; the N-atom labeled a, the two secondary amide 
nitrogens labeled b, the two imidazole nitrogens labeled e; f, and the two carboxylate 
oxygens labeled c. [Figure 2.2] 
 
For comparison of physical properties, measurements were also made on the related 










Glycyl-L-histidine was purchased from Sigma-Aldrich and was 99.0% pure    Glycyl-L-
histidine also has amide nitrogen and histidine moiety as shown in Figure 2.4.   This 
ligand is also expected to be selective to copper since it has several N-atoms, and it is 






















Figure 2.4: Glycyl-L-Histidine (the letters in purple font are used to 



















This ligand has several binding sites, from “a” to “g” as shown in purple font in       
Figure 2.4.   Glycyl-L-histidine is expected to form uncharged complexes with Cu(II) 
since it has an amide nitrogen and a carboxyl group.   Coordination to these two groups 
results in their deprotonation [9, 10]. 
 
2.3 SYNTHESIS OF THE LIGAND 
 
The synthesis involves two starting materials; methyliminodiacetic acid and L-histidine 
methyl ester.  This involves three steps; protection of the amino group, activation of the 
carboxyl group and de-protecting the amino group [12].   The first step of the synthesis 
was omitted because the nitrogen of the diacid was protected by the methyl group.   
Polymerization is common where the amino group is not protected [10]. 
 
To speed up the reaction and to eliminate side reactions, the carboxyl groups of the 
methyliminodiacetic acid was activated [13].   There were two main activation groups; 
carbodiimides and the aromatic oximes [9, 13]. The most common carbodiimides are 
dicyclohexylcarbodiimide (DCC) and diisopropylcarbodiimide (DIC) [10, 13]. 
Aromatic oximes are used to solve the problem of racemization [11].   This is the process 
in which one of the enantiomer of a compound converts to the other enantiomer [11, 12].   
The compound alternates between each form while the ratio between laevo and dextro 
approaches 1:1 at which point it becomes optically inactive.   The two common aromatic 
oximes are 1-hydroxybenzotriazole (HOBt) and 1-hydroxy-7-azabenzotriazole (HOAt) 
[13, 14]. 
 
2.3.1 EXPERIMENTAL  
2.3.1.1 Chemicals 
 
All chemicals and reagents were of analytical grade and were used without any further 
purification.   Methyliminodiacetic acid and L-Histidine methyl ester were purchased 












1-hydroxybenzotriazole (HOBt) was purchased from Sigma-Aldrich and was of 98.0% 
purity, dicyclohexylcarbodiimide (DCC) was purchased from Merck and it was of 99.0% 
purity, tetrahydrofuran (THF) and dimethylformamide (DMF) were purchased from 
Sigma-Aldrich, and triethylamine (Et3N) was purchased from Sigma-Aldrich and it was 




In the first reaction vessel, about 0.686mmol methyliminodiacetic acid was dissolved in 
THF and stirred continuously for 15 minutes and then 1.593 mmol DCC and 0.681 mmol 
HOBt added.   The system was stirred continuously and cooled to 0
o
C for 15 minutes.  
The reaction system was stirred overnight at room temperature under an inert atmosphere 
of nitrogen.   The reaction was monitored and the contents of the reaction system checked 
using paper chromatography [15-17].   In the second reaction vessel, 1.496 mmol L-
histidine was dissolved in EtN3.   When the chromatogram showed that there was no 
methyliminodiacetic acid left in the reaction vessel, the contents of the second reaction 
vessel were added into the first reaction vessel.   In some cases, a precipitated formed was 
isolated by evaporating the solvent before addition of L-histidine.   The reaction was 
stirred continuously for 18 to 72 hours at room temperature under an inert atmosphere in 






























 Where R is a reagent, S is a solvent, and Cat is a catalyst 
 
 
2.3.2 Results and Discussions 
 
When the structure of the product was examined using 
1
H NMR spectroscopy, there were 
no peaks showing around 3.22ppm, 3.67ppm and 4.81ppm as was expected.   
1
H NMR 
spectroscopy and elemental microanalysis confirmed that the product obtained was not 
the desired product.   The procedure was repeated but DMF was used to activate 
methyliminodiacetic acid instead of DCC.   The physical conditions (temperature and 
pressure) were also altered.   Repeated attempts to synthesize the desired product failed 
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Glass electrode potentiometry is one of the most reliable methods for studying chemical 
interactions in solution [1, 2, 3].   In this method, indicators are not used; instead the 
difference in potentials (emf) is used to predict the end point of a titration reaction.      
This makes glass electrode potentiometry more reliable over the other since the signals 
will be created by the analyte only not by the indicator plus the analyte.    Moreover, 
since there are no indicators used, which involve colour changes in most cases, and which 
only shows colour changes after an end point has been reached, errors due to such 
conditions are eliminated [2, 3].   
 
However, to use this method, a glass hydronium ion-selective electrode (indicator 
electrode), a suitable reference electrode and a sensitive potentiometer are needed [4, 5].      
To eliminate contamination from the atmosphere, a closed system is preferred.   The 
electrode should be calibrated after every titration, and all solutions used for this kind of 
titration should be standardized.   The composition of at least one of the analytes should 
be known.   Primary chemicals of a known weight are therefore used to standardize the 
acids/bases which can be used to standardize other solutions like the ligand solutions.   
Metal ion solutions should also be standardized by described methods [7-9].  
 
The potentiometric titrations are done at a fixed temperature and ionic strength. [4-6]   To 
find the end point from the potentiometric data, a Gran plot is constructed [10, 11].   For 
this method, an acceptable plot should have two slopes (one slope constructed before end 
point the other produced after the end point.   These two slopes have to meet at one point 
(end point), and should there be any difference between the two slopes endpoints, this 
indicates CO2 contamination which could affect the results since CO2 forms carbonic acid 













In this study, glass electrode potentiometry was used to study the interactions between the 
ligand and the protons and the interactions between the three metal ions (Cu(II), Ni(II) 
and Zn(II)), and the ligand; glycine and glycyl-L-histidine.    The potentiometric data was 
analysed using the Equilibrium Simulations for Titration Analysis (ESTA) software.   
This data was also used to predict the possible metal/ligand models and to predict the 




For the reaction; 
 
                                      L + H  LH 
 
 
Where L is the ligand, H is a proton and LH is a protonated ligand; the thermodynamic 
protonation constant 
T
K of the ligand can be expressed as; 
 
                                      
T
KL1 = {LH}                                                                             (3.1) 
                                                {L}{H} 
 
 
Where {LH} is the activity of the single protonated ligand, {L} is the activity of the 
ligand and {H} is the activity of the proton. 
 
Similarly,  
                                      {X} = X [X]                                                                          (3.2) 
 
Where {X} is the activity of species X, it can be a ligand, a proton or a metal ion, X is 
the activity coefficient of the species X and [X] is the concentration of X. 
 
Therefore,  
                                      
T
KL1 =    ( LH [LH])                                                                 (3.3) 


















Equation (3.3) can be rearranged as; 
 
                                                                                                                             (3.4) 
 
  
At constant ionic strength, 
                                    (3.5) 
 
 
Since the ionic strength is constant, the equilibrium constant can be expressed as; 
 
                                      K L1 =     [LH]                                                                         (3.6) 
                                                   [L][H] 
 
K L1, is the concentration equilibrium constant. 
 






K L3, the protonation 
constants can be described in a stepwise manner.   
 
                                      L + H  LH                                        KL1 =   [LH]                  (3.7) 
                                                                                                            [L] [H]    
 
 
                                      LH + H  LH2                                    KL2  =     [LH2]              (3.8) 
                                                                                                              [LH][H] 
 
 
                                      LH2 + H  LH3                                    K L3 =    [LH3]              (3.9) 
                                                                                                              [LH2][H] 
 
Likewise, for a ligand with n protonation constants, 
 
                                      LHn-1 + H  LHn                                  K Ln =        [LHn]         (3.10) 
                                                                                                               [LHn-1][H] 
T
KL1=    LH         [LH]   
            L H       [L] [H]   
             LH     = constant        













Similarly, for the metal M and the ligand L that react to give a complex ML, the stability 
constant (KML) can be described as; 
                                    
                                 M + L  ML                                        KML =   [ML]                  (3.11) 




                                 ML + L  ML2                                      KML2 =   [ML2]              (3.12) 
                                                                                                             [ML][L]    
Therefore,  
 
                                 MLn-1 + LH  MLn + H                         KMLn =   [ML n] [H]      (3.13) 
                                                                                                            [ML n-1] [LH]    
 
Moreover, the cumulative formation constant (overall formation constant),  can be 
expressed as;  
 
                                  L + H  LH                   L1 = KL1 =   [LH]                                (3.14) 
                                                                                            [L][H]    
 
 
                                 LH + H  LH2               L2 = KL1KL2  =     [LH2]                       (3.15) 





                                 LH2 + H  LH3              L3 = KL1KL2 K L3 =    [LH3]                 (3.16) 





                                 LHn-1 + H  LHn            Ln = KL1KL2K L3 ... K Ln =    [LHn]       (3.17) 




Similarily,   
 
                                  M + L  ML                   ML1 = KML1 =   [ML]                        (3.18) 














                   ML + L  ML2               ML2 = KML1KML2  =     [ML2]                           (3.19) 






                   MLn-1 + L  MLn            MLn = KML1KML2KML3 ... K Mn =    [MLn]          (3.20)                                                                     
                                                                                                              [MLn-1][L]
n
 
        
 
 
For the reaction; 
 
                             pM + qL + rH  MpLqHr  
 
Where p is the stoichiometric coefficient of M, q is the stoichiometric coefficient of L 
and r is the stoichiometric coefficient of H.   The formation constant ( ) of the reaction 
can be expressed as; 
 
             
                             pqr    =    [MpLqHr]                                                                           (3.21) 






   
 
    
Moreover, the concentrations of MpLqHr from each titration point can be determined and 
at point k, the concentration of MpLqHr is expressed as; 
 






                                                                        (3.22) 
 
The total concentration of the free metal ion at point k (TM,k) can be expressed as; 
 
                                                         N 





k                                                        
(3.23) 















The total concentration of the free ligand at point k (TL,k) can be expressed as; 
 
                                                       N 





k                                                            
(3.24) 
                                                      i=1 
 
 
The total concentration of the free hydronium ion at point k (TH,k) can be expressed as; 
 
                                                        N 





k                                                            
(3.25) 
                                                       i=1 
 
The coefficient of the proton (r) can be greater or equal to 1 if the complex is protonated.   
However, the r can have a negative value if the ligand lost all its protons upon 
complexation with the ligand, or if the hydroxide (OH) has been added to the complex. 
[10, 11]   If r = 0 then the complex is not protonated and there are no hydroxide ions 
attached to the complex.   ML indicates a complex that is not protonated, MLH indicates 
a complex that has been protonated with one proton, MLH2 for a complex that has been 
protonated with two protons and MLHn means a complex has one central metal ion, one 
ligand and n protons attached to the complex. 
 
 
Stability constants depend on temperature as shown by van’t Hoff equation; 
 
 
                             d InK = Ho                  OR            d InK = - Ho                                 (3.26)    




is the standard enthalpy change of the reaction (expressed in J.mol
-1
), T is the 




















The glass electrode potentiometry instrumentation is in the fashion; 
 
Reference electrode/ salt bridge/ analyte solution/glass electrode 
              Eref                      Ej                                                 Eg  
 
Each electrode possesses a half reaction.   The reference electrode potential, Eref, has a 
known constant value and it is not affected by the concentration of the analyte solution.   
Whereas the potential of the glass electrode, Eg, varies with the concentration of the 
analyte solution [12, 13].   The liquid junction potential, Ej, results due to the difference 
in concentrations of the analyte solution and the internal reference solution.   The 
observed potential, Ecell can therefore be expressed as  
 
                                  Ecell = Eref + Ej + Eg                                                                    (3.27) 
 
Since Eg varies with the concentration of the analyte solution, the Nernst equation can be 
written as; 
                                  Ecell = Eref + Ej + E
o
g+ RTIn{H}                                                (3.28) 




g is the standard electrode potential and {H} is the activity of the hydrogen ion.   
The activity of the proton is expressed as; 
  
                                  {H} = H [H]                                                                              (3.29) 
 
Where H  is the activity coefficient of the hydrogen ion and [H] is the concentration of 
the hydrogen ion.    
 
The ionic strength of the of the solution, I, can be expressed as; 
  
                                  I = 1/2 CiZi
2
                                                                                 (3.30) 












If the ionic strength and hence the activity coefficient of the H ions are constant then 
Equation 3.28 can be re-written as; 
 
                                  Ecell = Econst. + RTIn[H
+
]                                                             (3.31) 
                                                           F 
 
However, the potential depends on temperature and the relationship between the two 
varies with the activity of the hydrogen ion.   This can be expressed in terms of the slope 
factor, s. 
 
                                  s = 2.30RT                                                                                  (3.32) 
                                             F 
 
Putting Equation 3.32 into 3.31 yields;  
 
 
                                  Ecell = Econst. + s log[H
+
]                                                              (3.33) 
 






3.4.1 Preparation of Solutions 
 
All chemicals were of analytical grade and were used without any further purification.   




 as the background 
electrode.   Solutions of sodium hydroxide (0.1M) were prepared from Merck ampoules 
(1.09959-Trisol) in distilled deionised water they were prepared under an inert 
atmosphere of nitrogen gas.   These solutions were standardized with potassium hydrogen 
phthalate, KHP.   The solutions of hydrochloric acid (0.01M) were prepared from Merck 
ampoules (1.09970-Trisol).  These were then standardized with the standard solutions of 
sodium hydroxide using Gran method methods [11].   The metal solutions were prepared 
in distilled deionised water and standardized with reported methods for Cu(II), Ni(II) and 












times more dilute than the metal itself.  This was to prevent the metal ions from 
hydrolyzing.   The ligands were purchased from Sigma-Aldrich and Fluka. They were in 
powder form and were 99.0% pure.    
 
3.4.2  Potentiometric Measurements 
 
The  Metrohm glass electrode was calibrated with a set of  Metrohm ion analysis pH 
buffers from which pH and the Nernstian slope was determined. [11, 12]   The slope 
varied from 58.897 to 59.099.   All reactions were performed at 25
o
C, ionic strength of 
0.15M and pH range 2-11 using a  Metrohm 848 Titrino plus.   Strong acid/strong base 
titrations were carried out and the potentiometric data used to calculate the electrode 
response intercept, EO, from the slope and the negative logarithm of the water ion 
product, pKw, using the ESTA program. 
 
For the protonation of the ligand, an exact amount of the ligand was weighed into the 
reaction vessel and known volumes of standard HCl solution were added to it.   This was 
done such that complete protonation was achieved. The solutions were stirred 
continuously and gently with a  Metrohm 801 magnetic stirrer.   When a stable 
temperature of 25 0.1
o
C was reached the solutions of the ligands were titrated with 
standards solutions of sodium hydroxide.    
 
For the complexation of the ligands, exact amounts of the ligand was weighed into the 
reaction vessel and known amounts of the standard solutions of the metal ion solutions 
were then added.   The metal to ligand molar rations varied, between 1:1 and 1:2.   The 





















3.4.3 Data Analysis and Calculations 
 
The potentiometric data was used to calculate the protonation/deprotonation constants of 
the ligand and the stability constants of the complexes using Equilibrium Simulations for 
Titration Analysis (ESTA) program.   ESTA is a program that was designed to analyse 
potentiometric data of chemical species in solution [15, 16].   This program has two basic 
units, namely the simulation unit and the optimization units.   The simulation unit 
(ESTA1) characterises the system on a point by point basis.   It does this by using the 
mass balance equations.   This unit is used to calculate complexation functions which 
help in the interpretation of the data.   It can also be used to calculate the speciation of the 
solution.   The plotting unit (ESTA5) is used to put the parameters calculated by ESTA1 
in a graphic form.   
 
The optimization units (ESTA2A and ESTA2B) are used to optimize parameters that 
characterize the titration system as a whole [15].   They give the average values for the 
titration system.   Parameters can be refined using this unit.  Other units include the 
Monte Carlo error propagation unit (ESTA3B) which identifies which parameters need to 
be refined, and the error imposition unit (ESTA7) which is used to examine the effects of 
random errors on the values of the refined parameters. 
 
In this study, four tasks from the ESTA program were used.    From the potentiometric 
data, the ZBAR task was used to calculate the formation functions at each titration point.    
It is from this task that the calculated and the observed formation functions were 
compared and the residuals were calculated from Equation 3.40 and 3.41 for the proton 
formation functions and the metal formation functions respectively. 
 
                                  Residual pH = pH
O
 – pH 
C















Since the glass electrode is used to study the hydronium ion concentration;  
 






HlogH                                                          (3.36) 
Similarly; 
                               z-barH = TH – H + OH                                                                   (3.37) 
                                                      TL  
And;  
                                            z-barM = TL – A + ( n ßLHnH
n
 )                                       (3.38) 
                                                                            TM   
Where   
                                            A = TH – H + OH                                                             (3.39)                                                





For proton formation function,   
                   Residual formation function = z-bar
O
H -  z-barCH                                     (3.40) 
 
For metal formation function, 
                          Residual = z-bar
O
M -  z-barCM                                                            (3.41)               
 
Where; 
z-barH point residual = [( pH
O




  -  (z-barOH -  z-barCH)2]1/2                            (3.42) 
 
And; 
z-barM = [( pA
O


















 is the observed pH, pH 
C 
is the calculated pH, z-bar
O
H is the observed proton 
formation function ,  z-bar
C
H the calculated proton formation function, z-bar
O
M is the 
observed metal formation function,  z-bar
C
M is the calculated metal formation function, 
pA
O
 is the negative logarithm of the observed ligand concentration, pA 
C
 is the calculated 




H is the standard 
potential, 
S
H is the slope of the electrode and log H is the logarithm of the proton 
concentration,  TH is the total concentration of the hydronium ion, H is the concentration 
of the hydronium ion, OH is the concentration of the hydroxide ion, TL is the total ligand 
concentration, A is the ligand concentration, n is the number of protons bind to the 
ligand, ßLHn is the formation constant of the protonated ligand with n protons, TM  is the 
total concentration of the metal ion [15]. 
 
The second ESTA task is the QBAR.   This task is used to calculate the observed and 
calculated deprotonation functions.   Since the deprotonation function is defined as the 
average number of protons released by the ligand upon complexation with the metal ion 
then Q-bar is expressed as; 
 
                                                   Q-bar = (T*H – TH)                                                    (3.44) 
                                                                        TM 
                                                 
Where T*H is the calculated total concentration of protons in the system at the observed 
pH ignoring the presence of all the metal complexes.    
 
When                                    p = zero    and    OH = KW 
                                                                                   H 
 
The mass balance equations for T*H and TL and be written as;  
 
                                                                      N J 
                                           T*H = H – OH + r (MpLqHr)                                           (3.45) 














                                                                       N J 
                                              TL = L + OH + q (MpLqHr)                                          (3.46) 
                                                                       
J=1 
Where NJ is the total number of titration points. 
 
For binary systems, a formation function is defined for the ligand subsystem; 
 
 
                                            n-bar = (T*H – H + OH)                                                    (3.47) 
                                                                    T
r
L 
                                            
For any given M and L stoichiometry (p and q), the average proton stoichiometric 
coefficient (r-bar) can be calculated. 
 
                                         r-bar = (q x n-bar) – ( Q-bar x p)                                         (3.48) 
 
For ternary systems, the two formation functions,  nL-bar and nX-bar are defined as; 
                                                 nL-bar = r (LHr)                                                        (3.49) 
                                                                     T
r
L    
  
                                                nX-bar =    r (XHr)                                                     (3.50) 




If the complex is predominant in solution, the average proton stoichiometric coefficient 
can be calculated given any M, L and X stoichiometry (MpLqXsHr)      
 
                                                                                













The third task (OBJE) was used for weighting the objective function (Uobj) contribution 
based on the observed emfs and the relative contributions of the most significant errors to 
the weight at each titration point.    This function is expressed as; 
 
                                             N            ne 










                                              (3.52)  
                                            
n =1       q=1   
Where;  
N is the total number of experimental titration points, np is the total number of points 
being optimized, ne is the total number of electrodes, wnq is the is the weight of the q
th
 




 is the observed variable at the of the q
th













Data are optimized by minimizing the objective function.   This can be achieved by 




Uobj  can therefore be expressed as; 
 




Hp)                                                                            (3.53) 
                                                   2 
 
Where a and b are Gauss-Newton quadratic parameter vectors, p is optimization 
parameter vector, p
t
 transpose of p and Hsr is the Hessian.   Hsr is expressed as; 
 
                      Hsr = d
2
Uobj                                                                                             (3.54) 
                             dpsdpr 
 
The last task of the ESTA program that was used was the OBJT.    This works like OBJE 
except that OBJT the weighting of the objective function is based on the total ion 














The program also calculates the standard deviations, estimated errors for the parameters 
being optimized using the method of least squares.   The standard deviation σ can be 
expressed as; 
 
                     σ =       Uobj Grr
    ½   
                                                                                (3.55)                            
                                 (N – np)                    
 
The Hamilton R-factor (R
H
) can be used to test the agreement between the observed and 
the calculated values of the refined data.   This factor can be expressed as; 
 
 
                  R
H
 =                    Uobj            
½
                                                                  (3.56) 









The best possible R
H
 value based on the number of variables and the random errors in the 
analytical, R
H
lim can be expressed as; 
 
                       Rlim
H
 =                    N                 
½
                                                       (3.57) 









 is less than R
H
lim the model is within the maximum allowed experimental error. [15] 
 
In general, Z-bar was used to estimate the protonation constants of the ligand and the 
stability constants of the complexes.  From the ZH-bar, the number of protons bound per 
ligand was estimated, and from the ZM-bar the number of the ligand bound per metal ion 
were calculated.   From the Q-bar, the number of protons released by the ligand upon 
complexation with the metal ion was estimated.   Q-bar was compared to the n-bar which 














The distribution template of the ESTA programs was used to calculate the distribution of 
the ligand the metal complexes in solution respectively.   The distribution of the ligand 
depends on the optimised protonation constants and the acid and ligand concentrations, 
while the distribution of the metal complexes depends on the optimised ligand 
protonation constants, the optimised stability constants, the ligand concentrations, the 




For all the experiments, the slope varied from 58.986 to 59.123; the pKw varied from 
13.768 to 13.721; and the E
o
 varied from 399.29 to 414.153 millivolts.   The titrations 
were done in the pH range 2-11 with a glass electrode.   All titrations were done at a fixed 
temperature of 25 1 
o
C and a fixed ionic strength of 0.15M with NaCl as the background 
electrolyte.   For the protonation titrations, the ligand was dissolved in standard HCl 
solution and titrated with the standard NaOH solution.   The concentrations of the ligand 
varied but they were all around 0.001M.   The concentrations of the standard solutions of 
HCl and of NaOH varied but they were around 0.001M and 0.01M respectively. 
 
For the complex formation reactions, the concentrations of the standard metal ions 
solutions varied and the concentrations of the ligand solutions varied.   However, 1:1 
metal/ligand systems were made of around 0.001M standard metal ion solutions in 
0.0001M HCl and around 0.001M ligand in distilled deionised water.   The 1:2 
metal/ligand systems were made of around 0.001M standard metal ion solutions in 
0.0001M HCl and around 0.002M ligand solutions in distilled deionised water, except for 
the complexes of glycyl-L-histidine with Ni(II) where around 0.0005M of standard metal 
ion solutions in 0.00005M HCl and around 0.001M ligand in distilled deionised water 
were used.   The concentrations of the standard solutions of NaOH varied but they were 
















3.5.1   Protonation of Glycine 
 
The glycine system was studied for two reasons.   Firstly it is a well known system and 
hence provided an internal check on the reliability of the experimental system including 
the operator.   Secondly it is part of the molecule of interest and would provide a useful 
reference.  When glycine was titrated with a NaOH the Z-bar levelled off at 1 and the 
rose up above 1.6 at pH 2.0.    As the acid was neutralised, Z-bar levelled off at 1 and 
then, at pH 8.0 decreased to 0.   This gives confidence to our experimental procedure.   

















The results were in good agreement with the literature values [16, 17].   The standard 
deviations were small and the R
H
 was less than R
H
lim thus the model is within the 



















































The speciation graph for protonation of glycine is shown in Figure 3.2.   The most 
predominant form of the ligand was LH which formed below pH 2.0.   At pH 2.0, 33.68% 
of the ligand was LH and 66.32% was LH2.   Around 96.70% of LH was formed from pH 
3.81 to pH 8.21 where it began to fall gradually.   The deprotonated ligand began to form 














2.34( 2)2.290.0211.820   1   2
9.50( 4)9.53
4(204)0.010.003







p  q   r
Table 3.1: Literature and experimental protonation constants of glycine. Log ßpqr is the logarithm 
of the sum of overall stability constants,  is the standard deviation of the Log ßpqr,  RH  is the 
Hamiltonian R-factor, Rlim is the Hamiltonian R-limit, nT is the number of titrations, (nP) is the 
number of titration points, Log Kexp is the logarithm of the experimental stability constants and Log 
Klit is the logarithm of the stability constants got from literature. [14]      
                

































3.5.2 Protonation of Glycyl-L-Histidine 
 
Figure 3.3 shows the plot of the formation function, Z-bar as a function of pH for the 
protonation of glycyl-L-histidine.   The Z-bar plot changed direction at pH 7-8, rose up 
and then levelled off at z-bar = 2 (pH 4-6) and increased slightly above 2.75.   This 
implies that the ligand has three dissociable protons.   Full protonation of the ligand 
occurred at a lower pH, below pH 2 that is why the z-bar plot could only go to 2.75.   

























The experimental values of the protonation constants of the ligand estimated using 
ESTA1 were optimised using ESTA2.  The experimental and literature 
protonation/deprotonation constants of glycyl-L-histidine are presented in Table 3.2.    
The three protonation constants of glycyl-L-histidine are 8.34,   6.61 and 2.29 



























respectively.   The standard deviations were small and the R
H
 was less than R
H
lim thus the 
model is within the maximum allowed experimental error.   The Log K values did not 
differ significantly from the literature values.   The theoretical plot is represented by a 
solid line in Figure 3.3.   The agreement between the theoretical and the experimental 



















Logarithms of the overall protonation constants, log ßs, were used to calculate the 
distribution of L, LH, LH2 and LH3 species in solution.   The calculations were performed 






Table 3.2: Literature and experimental protonation constants of glycyl-L-histidine. Log ßpqr is the logarithm 
of the sum of overall stability constants,  is the standard deviation of the Log ßpqr,  RH  is the Hamiltonian       
R-factor, Rlim is the Hamiltonian R-limit, nT is the number of titrations, (nP) is the number of titration points,  
Log Kexp is the logarithm of the experimental stability constants and Log Klit is the logarithm of the stability 
constants got from literature. [14]      
                
2.52( 2)2.290.0517.240   1   3
6.70( 7)6.610.0314.950  1   2
8.14( 8)8.34
4(204)0.010.004



































Complete protonation of glycly-L-histidine occurred at a very low pH and at pH 2.00 
there was about 70.44 percent of the LH3 species and 29.56 percent of the LH2 species.   
This is shown in Figure 3.4.   Around pH 2.38, the amount of LH3 species was equal to 
the amount LH2 species.   The latter then dominated the system after pH 2.38 to around 
pH 6.43.   The LH species dominated the system from pH 6.52 to about pH 8.25 but a 
maximum of 77.29 percent of it was formed since three species were present in this pH 
range, LH2, LH and L.   The neutral form of the ligand began to form at pH 6.60 and 
92.68 percent (plus) of it was formed from pH 9.51. 
 
3.5.3 Complex Formation Titrations 
 
3.5.3.1 Cu(II)/Glycine System 
 
When glycine was complexed with Cu(II), 2:1 glycine to Cu(II) molar ratio, the ZM-bar 
leveled at ZM-bar = 2.   The ML2 were therefore the most predominant species in 
solution.   This agrees with literature   [14, 16].   The ZM-bar curve for the Cu(II)/glycine 






































is shown in Figure 3.5.   Moreover,  ZM-bar did not bend backwards because there no 

















The QM-bar for the Cu(II)/glycine system is shown in Figure 3.6.   The leveling of n-bar 
at one means the ligand has one dissociable proton, however, the QM-bar rose to a 
maximum of around 1.86 therefore glycine lost two protons upon complexation with 
Cu(II).   This agrees with the reported data for Cu(II)/glycine [14, 16, 17].   Comparing 
the ZM-bar of Cu(II)/glycyl-L-histidine system and the  ZM-bar of Cu(II)/glycine system, 
the latter rose until a maximum of ZM-bar = 1.86 was reached, it dropped down gradually 
and never rose up again.   This confirms that there were no hydroxide species formed in 







































The stability constants were summarized in Table 3.3.   There was no significant 
difference between the experimental results and the literature values of the log K.   The 
standard deviations and R
H
 were small, and R
H
 was less than R
H
lim therefore the errors 













15.0( 1)15.110.00615.111   2   0
8.15( 9)8.09
4(216)0.010.003







p  q   r
Table 3.3: Literature and experimental stability constants of Glycine and Cu(II). Log ß pqr is the 
logarithm of the sum of overall stability constants,  is the standard deviation of the Log ßpqr,  RH  
is the Hamiltonian R-factor, Rlim is the Hamiltonian R-limit, nT is the number of titrations, (nP) is 


































The speciation curve for the complexation of glycine with Cu(II) is shown in Figure 3.7.   
The ML species began to form from pH 2.35.   A maximum of 78.60% of the ML species 
was formed at pH 4.82, and the species began to fall gradually after this pH.   At pH 6.22, 
all the Cu(II) was used up.   The ML2 species formed from pH 3.76, about 93.29 of LM2 

















3.5.3.2  Cu(II)/Glycyl-L-histidine System 
 
The stability constants of the Cu(II)-ligand solutions were calculated with ESTA program 
from the potentiometric data.   The data was put in the metal/ligand template of ESTA 
and the protonation constants of the ligand were also put into the template.   From the 
potentials and the protonation constants of the ligand, the stability constants of the ligand 
complexes were calculated and optimised as mentioned earlier [13].   The ML species 


























































For clarity, some of the data points are omitted.   The solid line is the theoretical curve 
calculated using results given in Table 3.4.   Figure 3.8 shows the ZM-bar curve for 
Cu(II)/glycyl-L-histidine system.  ZM-bar levelled off at ZM-bar = 1 at pH range 3.70 to 
7.85.   This indicates that the ML species is predominant in this pH range.  Figure3.8 was 
plotted using ESTA5 and the proportion of the metal ion concentration to ligand 
concentration varied from 1:1 Cu(II)/ligand to 1:2 Cu(II)/ligand ratios.   The ZM-bar for 
1:1 Cu(II)/ligand system curved backwards  at ZM-bar = 1 and that of a 1:2 Cu(II)/ligand 
curved backwards at ZM-bar = 2.   The ZM-bar function is really only defined for simple, 
stepwise mononuclear complexation.   Hence, when the ZM-bar function deviates from its 
normal shape, this indicates that other, more complex species are forming.   In this case 
the ZM-bar function curves back indicating the formation of deprotonated or hydroxy 
species.   The solid line represents the theoretical plot.   The agreement between the two 
gives us confidence in the model. 
ZM-bar as a Function of pH for the 




























Since the ZM-bar function rapidly becomes undefined when hydroxy species are formed 
we can use the deprotonation function to depict the data.   The deprotonation function for 
the complexes of Cu(II) and the ligand are plotted in Figure 3.9.   The levelling off of the 
n-bar at n-bar = 2 means the ligand has two dissociable protons.   Due to complexation by 
Cu(II), the ligand began to lose protons from around pH 3.34.   At pH 4.8, the n-bar and 
Q-bar functions intersect and then the Q-bar rises to about Q-bar = 2.2.   This indicates 
that more protons are released from the ligand than were present in the first place.   This 
could happen if one of the amides lost a proton or if a coordinated water molecule lost a 
proton.    
 
Thermodynamically these two processes are the same.   Between pH 6 and 8, the n-bar 
and Q-bar curves run parallel.   This means that in this pH range no change in 
complexation is taking place (in the analysis of the data, these points would just add to 
the total experimental error).   The ML species formed from pH 3.34 to pH 4.95 where 
complexation completed and there was no change in speciation until at pH 9.37 where the 
















Figure 3.9: QM-bar as a function of pH for Cu(II)/Glycyl-L-histidine 
system 































The potentiometric data was analysed using ESTA2 with the results shown in Table 3.4.   
The experimental model is different from the literature model, but the stability constants 





















When the model similar to the literature one was put into ESTA, there were significant 
differences between the observed and calculated pHs, Z-bars, and some species showed a 
zero concentration from the first point of the titration to the last.   This indicated that the 
literature model was not appropriate to our experimental conditions.   In both Figure 3.8 
and 3.9 the solid line was calculated assuming the model and constants given in Table 3.4 
were correct.   The agreement between the theoretical curves and the experimental data is 
excellent and lends confidence to our results.  The standard deviations were small and the 
Table 3.4: Literature and experimental stability constants of Glycyl-L-Histidine and Cu(II). Log ß pqr 
is the logarithm of the sum of overall stability constants,  is the standard deviation of the Log ßpqr,  RH  
is the Hamiltonian R-factor, Rlim is the Hamiltonian R-limit, nT is the number of titrations, (nP) is the 





-12.0411   1   -2
4.09( 6)




1    1   1
2.0030.017-22.1751    1  -3
16.16( 1)-(ML2 not observed)1    2   0
8.98( 8)9.162
4(204)0.0090.004








p   q    r














 was less than R
H
lim therefore the model is within the maximum allowed experimental 
error. 
 
The species distribution curve for the complexes of glycyl-L-histidine and Cu(II) is 
shown in Figure 3.10.   At pH 2, there was 100 percent of the free metal ion species. 
Around pH 2.08, the ML species began to form.   At pH 4.90, all the metal ions were 
used up and 100 percent of the ML species was formed.  The ML species began to fall at 
pH 7.18 where the formation of MLH-1 commenced.   The MLH-1 was formed at the 
expense of the ML species.   About 100 percent of the MLH-1 was formed at pH 10.02 
even though there was a rapid fall soon after that.   A maximum of 3.42 percent of the 
















































Figure 3.10: The distribution curve for the  Cu(II)/Glycyl-L-histidine system 












3.5.3.3 Ni(II)/glycyl-L-histidine systems 
 
The stability constants of the complexes of glycyl-L-histidine and Cu(II), were compared 
with the stability complexes other metal ions, Ni(II) and Zn(II), under the same 
environmental conditions.   The metal to ligand composition ratio varied from 1:1 and 1:2 
for all the metal to ligand titrations.   The ZM-bar for the complexation of Ni(II) with 
glycyl-L-histidine is shown in Figure 3.11.   The    ZM-bar curves start to fan back almost 























Figure 3.12 shows the Q-bar for the complexation of Glycyl-L-Histidine with Ni(II).     
The levelling off of the n-bar at n-bar = 2 means the ligand has two dissociable protons.   
The ligand began to lose protons from around pH 2.26 upon complexation with Ni(II).   
There between n-bar and the Q-bar curves intersect at pH 6.47 and at pH 6.61, and the Q-
bar rises to a maximum of about Q = 2.26.   For both systems, the 1:1 metal/ligand and 
Figure 3.11: ZM-bar as a function of pL for Ni(II)/Glycyl-L-histidine 
system.  
ZM bar as a function of pL for the Complexation 
























1:2 metal/ligand systems, two protons were lost when the ligand was complexed with 
Ni(II).   The graph drops down and runs parallel to the n-bar.   The Q-bar rose above n = 
2 because hydroxide species were formed.  The Q-bar dropped because complexation 
was complete.   The bending of the graphs shows the presence of the hydroxide species in 
solution.   The model is within the maximum allowed experimental error because the 
standard deviations were small and the R
H



















The stability constants of the complexes of Ni(II) and glycyl-L-histidine are presented in 
Table 3.5.   The stability constant of the ML species of the Cu(II)/glycyl-L-histidine 
system is greater than the stability constant of ML species of the Ni(II)/glycyl-L-histidine 
system (log K for ML in the Cu(II) = 9.162 and the log K for the Ni(II) = 5.532).   The 
MLH-1 from the Cu(II)/glycyl-L-histidine system were less stable than the MLH-1 species 
from the Ni(II)/glycyl-L-histidine system (the log K for the Cu(II) system for MLH-1 was 
4.840 and log K for MLH-1 for the Ni(II) is 6.032).   Other species got from the Cu(II) 
system were not similar to the species got from the Ni(II) system.   However, the 
experimental values of the log Ks were comparable with the log Ks got from literature for 
Figure 3.12: QM-bar as a function of pH for Ni(II)/Glycyl-L-
histidine system 
 
QM-bar as a function of pH for the Complexation 































the Ni(II)/glycyl-L-histidine system except for log K of the ML2 species which was  
significantly different from the log of the same species from literature. 
















Figure 3.13 shows the distribution of species for the Ni(II)/ligand system.   At pH 2.29, 
the MLH species began to form.   The splitting of the graph indicates the presence of the 
MLH species.   A maximum of 56.46% of these species was observed at pH 5.81.   At pH 
4.56, the ML species began to form.   Only 14.97% of the ML species were observed in 
solution and this was observed at pH 6.16.   The ML2 and MLH-1 species began to form 
around the same pH, at pH 5.28.   A maximum of 62.02% of ML2 was observed at pH 
6.87, and a maximum of 22.61% of MLH-1 species was observed a pH 6.60.   The     
ML2H-1 began to form at pH 6.08.   At pH 9.51, there were only two species in solution, 






Table 3.5: Literature and experimental stability constants of Glycyl-L-Histidine and Ni(II). Log 
ß pqr is the logarithm of the sum of overall stability constants,  is the standard deviation of the 
Log ßpqr,  RH  is the Hamiltonian R-factor, Rlim is the Hamiltonian R-limit, nT is the number of 
titrations, (nP) is the number of titration points, and Log Klit is the logarithm of the stability 
constants got from literature. [14] 
 
3.423.530.0022.7501   2   -1
6.04( 4)6.0320.011-1.7081    1  -1
6.666.5620.00811.7661    1   1
9.62( 3)8.9790.03414.5111    2   0
4.685.532
6(424)0.0110.009













































3.5.3.4  Zn(II)/glycyl-L-histidine systems 
 
 
Figure 3.14 shows Z-bar for the complexation of the ligand with Zn(II).   This was 
plotted using two sets of data, data from a 1:1 metal/ligand system and data from 1:2 
metal ligand systems.   The graph levels off around Z-bar = 0.48.   The ML species were 
therefore not predominate species in solution.   In fact this levelling off indicates the 
formation of a protonated species.  The bending off of the graph at z-bar = 1 is due to the 
presence of the hydroxide species from a 1:1 metal/ligand system, and the bending off of 































Figure 3.13: The distribution curve for the Ni(II)/Glycyl-L-histidine system. 






























Figure 3.15 shows the Q-bar for the complexation of Glycyl-L-Histidine with Zn(II).     
The levelling off of the n-bar at n-bar = 2 means the ligand is capable of losing two 
protons upon complexation with a metal ion.   The ligand began to lose protons from 
around pH 4.36 upon complexation with Zn(II).  The splitting of the graph indicates the 
presence of the MLH species.   There are intersections between n-bar and the Q-bar at  
pH 6.18 and at pH 6.57, and the Q-bar rises to a maximum of about Q = 2.76 and Q = 
1.50 for graph a and graph b respectively.   In a 1:2 metal/ligand system, three protons 
were lost as a result of complexation between the metal ion and the ligand, and in a 1:1 
metal/ligand one proton was lost.   The graphs drop down and run parallel to the n-bar.   
The Q-bar rose above n = 2 because the hydroxide species were formed.  The Q-bar 
dropped from pH 7.36 (graph a) and pH 7.40 (graph b).   Graph a rose again at pH 9.06 






















































The stability constants for the Zn(II)/glycyl-L-histidine  complexes are shown in       
Table 3.6.   Log K for the ML species for the this system is less than the stability 
constants for the same species of the Ni(II) and the Cu(II) systems.   The ligand (glycyl-
L-histidine) therefore forms more stable complexes with Cu(II) than it does with Ni(II) 
and Zn(II).   However, the ML were the only common species in the Cu(II) and in the 
Zn(II) systems.   The Ni(II)/glycyl-L-histidine system shared three similar species with 
Ni(II)/glycyl-L-histidine system; ML, MLH and ML2 species.   The stability constants of 
all the three complexes (ML, MLH and ML2) in Ni(II)/glycyl-L-histidine were greater 
than the stability constants of the same complexes for the Zn(II)/ glycyl-L-histidine 
system.   Glycyl-L-histidine thus forms more stable complexes with Ni(II) than it does 
with Zn(II).   The standard deviations were small compared to the log  values and the 
R
H
 was less than R
H





QM-bar as a function of pH for the 

























































Figure 3.16 shows the distribution curve for the species in Zn(II)/glycyl-L-histidine 
system.   The most predominate species in this system were the ML2 species which were 
produced from pH 3.94.   This species dominated the system after around pH 5.17 where 
both the Zn(II) and the ML2 were at the percentage, 70.27%.   MLH started forming from 
pH 3.24.  The production of this species (MLH) increased until a maximum of 32.60% 
was reached, at 5.32 where after it dropped gradually until it reached zero at pH 6.76.   
The ML and the M2L2 both started to form from pH 5.00.    A maximum of 13.60% at  
pH 5.70 for the ML species and a maximum of 2.60% for the M2L2 at pH 5.88 were 
attained.   The small amount of M2L2 species both formed is reflected by the high 
standard deviation of log  for this species.   The quantity of ML decreased until all the 
ML were used up at pH 7.11, and the amount of the   M2L2 species decreased after the 
maximum  was reached.   At pH 6.93 M2L2 were used up.   The amount of the free Zn(II) 
ions decreased with pH, at pH 7.11 all the Zn(II) was exhausted, and at the same pH the   
Table 3.6: Literature and experimental stability constants of Glycyl-L-Histidine and Zn(II).  Log 
ß pqr is the logarithm of the sum of overall stability constants,  is the standard deviation of the Log 
ßpqr,  RH  is the Hamiltonian R-factor, Rlim is the Hamiltonian R-limit, nT is the number of titrations, 
(nP) is the number of titration points, and Log Klit is the logarithm of the stability constants got from 
literature. [14] 
 
7.036.9980.0234.1002    2  -1
11.1110.9480.05111.6892    2   0
9.91-(MLH-2 not observed)1    1  -2
6.73-(MLH-1 not observed)1    1  -1
6.896.0210.01310.7981   1   1
7.9( 2)6.1780.01610.2091   2   0
3.984.031
6(418)0.0150.008



























MLH-1 began to form.   The amount of ML2 in solution decreased gradually with 




















3.5.4   Discussion 
 
Comparing the stability constants of the ML species of glycyl-L-histidine with Cu(II), 
Ni(II) and Zn(II), the stability constant for these species in Cu(II) system were greater 
than the stability constants in Ni(II) and Zn(II).   This is the normal trend one would 
expect from the Irving Williams stability series.   
 
 
Moreover, the ML species in the Cu(II) were observed from pH 2.43 to pH 10.71, a 
maximum peak was reached from pH 4.54 to pH 7.54 (amount of ML at pH 4.54 to      
pH 7.54 varied from 94.54% to 99.91%).   The maximum of 11.94% of the same species 
in Ni(II) system was observed.   ML species in Ni(II)/glycyl-L-histidine system were 
observed at pH range 4.75 to 7.84.   ML in the Zn(II) system were observed from pH 5.00 
































































to pH 6.93, and a maximum of 13.60% of these species in Zn(II)/glycyl-L-histidine 
system were observed. (Figures 3.5, 3.8 and 3.11) 
 
The ML2 and the MLH species were not observed for Cu(II).   The stability constant (log 
K = 8.979) for the ML2 system in the Ni(II) had a  larger value than the stability constant 
(log K = 6.178)in the Zn(II) system by 2.801 log units.   In addition, the stability constant 
(log K = 6.562) for the MLH species in the Ni(II) was 0.541 log units greater than the 
stability constants (log = 6.021) of the same species in the Zn(II) system.   However, 
literature shows the opposite [17].   From literature [17], the Zn(II) MLH species was 
0.23 log units more stable than the Ni(II) complex (Table 3 and Table 4).   This 
contradicts the Irving Williams stability series.   Hence we have confidence in our results. 
 
A Zn(II) stability constant greater than that of Ni(II) would also contradict                 
Irving-Williams stability series; [18, 19] 
 
Mn(II) < Fe(II) < Co(II) < Ni(II) < Cu(II) > Zn(II) 
 
The deviations from Irving-Williams stability series may be due to the change of spin or 
conformation of the central metal ion [18, 20].   In this case, Ni(II) complex may go from 
octahedral to square planer which would increase the stability of the complex. 
  
However, the stability constant (log = 6.032) of the MLH-1 species in the Ni(II) system 
was greater than the stability constant (log K = 4.840) of the same species in the Cu(II) 
system by 1.192 log units.   This illustrates the difficulty of comparing stepwise stability 
constants when hydroxyl species are formed.   The stability constant includes both the 
complexation of the ligand and the loss of a proton.   Rather than comparing logK, one 
should, in this case, look at logβ.   These are -1.7 and 0.38 for Ni(II) and Cu(II) 
respectively.   The stability constants for MLH-1 in both systems were not significantly 














The MLH-2 and MLH-3 were not observed in the Ni(II) and in the Zn(II) systems, and 
there was no data on the stability constants of MLH-3 in the Cu(II)/glycyl-L-histidine 
system from literature.   However, the standard deviation of log 11-3 was quite small. 
ML2H-1 species were observed in the Ni(II) system but they were not observed in Cu(II) 
and in Zn(II) systems.  However, the σ1 2-1 was small and the log K for this species was 
not significantly different from the literature value since the literature values were done at 
a lower ionic strength (I =0.1M) and the ionic strength for the experimental was 0.15M.   




Glycine has two dissociable protons and glycyl-L-histidine has three dissociable protons.   
The LH form of glycine was more stable than the LH form of glycyl-L-histidine.   
However, this form (LH) exists at very low pH’s for both ligands.   The speciation for the 
protonation of glycine and that of glycyl-L-histidine showed that at pH 4 there was very 
little LH in solution.   The LH2 form of glycine was less stable than that of glycyl-L-
histidine.   The second protonation constant of glycine was equal to the third protonation 
constant of glycyl-L-histidine.. 
 
When glycine was complexed with Cu(II), there were only two species formed, ML and 
ML2.   There were no hydroxide species formed and the Q-bar plot for this system did not 
show any oscillations as a result.   Glycyl-L-histidine formed four different species with 
Cu(II); ML, MLH-1, MLH-2 and MLH-3.   The ML species of glycine were less stable 
than that of Cu(II) and glycyl-L-histidine.   However, the ML2 of Cu(II) and glycine were 
more stable than the other three species formed between glycyl-L-histidine and Cu(II); 
MLH-1, MLH-2 and MLH-3. 
 
The ML species of Cu(II) and glycyl-L-histidine was more stable than that of Zn(II) with 
glycyl-L-histidine and of Ni(II) with the same ligand.   The Ni(II)-glycyl-L-histidine 
complex that existed in the form MLH-1 was more stable than that of Cu(II)-glycyl-L-
histidine.   This species was not observed in the Zn(II) system.   Unlike Cu(II), both 












species formed between Zn(II) and glycyl-L-histidine was the most stable complex of all 
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4. ISOTHERMAL TITRATION CALORIMETRY 
4.1 INTRODUCTION 
 
Calorimetry is a technique used to study thermodynamic properties of chemical 
interactions [1-3].  There are three different methods in which calorimetric measurements 
can be made, and there are three different calorimetric instruments for each method; 
adiabatic or isoperibol system, the heat conduction calorimetry and the isothermal 
titration calorimetry. 
 
A calorimeter that has a temperature controlled jacket can be operated in two modes, the 
adiabatic mode and the isoperibol mode [2].   In an adiabatic system, the temperature of 
the reference cell is adjusted throughout the experiment to keep it equal to the 
temperature of the sample cell [1].   Therefore there is no heat transfer between the 
sample cell and the reference cell.   The heat of the reaction is then given by Equation 4.1 
[1, 2].   The signal for this technique is in 
o
C/sec (temperature units per unit time).   The 
heat change, q, can be calculated from the energy equivalent of the calorimeter 
equivalent, c [1, 5, 6].    
 
                                         q = c T                                                                              (4.1) 
 
For the calorimeter that is in an isoperibol mode the temperature of the reference cell is 
kept constant throughout the experiment while the temperature of the reference cell is 
changing [2].   In this case, there is heat transfer between the two cells and it needs to be 
corrected to account for the heat loss between the sample cell and the reference cell [2].   
The raw signal is the same as the one for adiabatic calorimetry and the heat change is also 















The heat conduction calorimeter has a heat flow sensors coupled with the heat sink that is 
kept at a constant temperature.   These sensors are connected to the reference cell.   The 
sensors are used to monitor the temperature change ( T) of the sample cell.   The raw 
signal for this method is the voltage; this voltage varies with T that is created by the 
chemical reaction [1, 7, 8]. 
 
In isothermal titration calorimetry (ITC), the temperature of the sample cell is kept 
constant.   The sample cell is connected to the temperature controllers.   During a 
chemical change, the heat gained (or lost) is detected and the power applied to the heat 
controllers changes accordingly to keep the temperature of the sample cell constant.   The 
raw signal for this method is in the units of power (μCal/sec or μJ/sec) [1, 7].  The raw 
signal is converted to H by integrating it (the raw power) over the time it took the heat 
controllers to reach the baseline value [1]. 
 
In this study, ITC was used to determine equilibrium constants (K) of the complexes at 
different pH.   It was also used to determine the heats of binding ( H) of the complexes, 
the entropy ( S) and the number of ligands (N) bound to the Cu(II) ions.   ITC was 
chosen over the other calorific methods because all four variables; K, H, S and N can 
be obtained from a single ITC experiment at a fixed pH with a corresponding buffer, and 
since the functions of the instrument are operated with a software the results conversions 
of the raw signal to the final ITC results are faster and accurate [7, 8].   With modern ITC 
calorimeters, direct measurements of the binding constants (equilibrium constants) can be 

















 can be covered [1].   
 
In addition, ITC can be used to analyse coloured solutions, all complexes of Cu(II) used 





C, pressure range of 700 Pa to 1060Pa in humid 
environments (humidity of 0 to 70%).   G was calculated from K, H, S and N using 














However, the technique has limitations.   The method only gives the conditional binding 
constants since the system consists of the metal ions, the ligand, the buffer and the 
complexes.   Also equilibrium constants are not as precisely determined as with glass 
electrode potentiometry.    
 
Isothermal titration calorimetry is often used for biological applications where the 
interaction of the buffer and metal ion are ignored.   Since the concentration of the buffer 
is normally much higher than that of the metal ion and since it is known, that in the 
absence of a buffer, at biological pH’s, the metal ion would precipitate as the hydroxide, 
this assumption is very strange.   What is actually being measured is: 
 
MBHn + L  ML + BHn 
 
Where MBHn is the protonated metal ion-buffer complex, BHn is the buffer with n 
number of protons and ML is the metal-ligand complex.   Moreover, since both the 
sample (metal ion solution) and the burette contents (ligand) are buffered the final ITC 
measurements is the summation of the heats of ionization of the buffer, heats of dilution 
of the buffer and the heats of binding of the ligand to the metal ion. 
 
The protonation/deprotonation constants of the ligand could not be studied with this 
method since the ITC measurements were done at a fixed pH with corresponding buffers.   
The sequential analysis of the complexation of the ligand with the metal ions, which 
could help characterize the individual species in solution and to observe how the 
speciation varies with pH change was also not possible for the same reason.   If the 
buffers are not used, the titration system will produce heats of neutralization which are 




















Moreover, the analysis could not be done at lower pH since acidic solutions may corrode 
the ITC sample cell.    The analysis at pH above 8 were also not possible since copper(II) 




In this study, there are n number of species in solution, the free ligand, free copper(II) 
ions and the complexes formed.  A basic understanding of this system would require the 
knowledge of two primary thermodynamic parameters, the equilibrium constants for the 
binding process, K, and the binding stoichiometry , N [1, 3].  A more advanced way of 
understanding this interaction can be established if the enthalpy change ( H) and the 
entropy change ( S) for the formation of the complex are known [1, 2, 4].  The 
thermodynamic relationship of the three species, the free ligand, copper(II) ions and the 
complexes can be established by the Equations 4.2 to 4.9 [1, 3, 5]. 
 
For the reaction; 
 
M + L  ML 
 
The binding constant, K can be expressed as; 
 
                                      K   =    [ML]                                                                           (4.2) 
                                                 [M][L]   
 
Where [ML] is the concentration of the complex, [L] is the concentration of the free 
ligand and [M] is the concentration of the free metal ion.   The dissociation constant, Kd 
can be expressed as; 
 
                                      Kd   =    [M][L]                                                                         (4.3) 

















                                      1    =    [M][L]                                                                          (4.4) 
                                     Kd          [ML]   
 
Putting Equation 4.4 into Equation 4.2 yields; 
                                      1    =   K                                                                                    (4.5) 
                                     Kd            
 


















From Figure 4.1, M and L gain energy to get to the transition state, and the product (ML) 
has a lower overall energy compared to the energy of M and the energy of L at their 
ground state.    The Gibbs free energy change depends on the temperature.   For any 
reaction, the Gibbs free energy change can be expressed as; 
 
                                   Go = -RTln K(eq)                                                                                          (4.6) 
M + L 
Transition state 
    M* L* 
    ML 
Figure 4.1: A typical free energy diagram for a free metal ion M 
and a free ligand L going into ML (complex).   M* and L* are 













          
The actual G of the reaction can be expressed as;  
 
 
                                   G = Go + RTln K                                                                                          (4.7) 
 
 
Putting Equation 4.2 into Equation 4.7 yields; 
 
                                   G = Go + RTln     [ML]                                                                            (4.8) 
                                                                     [M][L]     actual 
 
  The relationship between G, H, T and S is expressed as; 
 
 
                                G = H-T S                                                                    (4.9)                        
 
 
Where K(eq) is the equilibrium constant, [M], [L] and [ML] are the concentrations of the 
free metal ion, free ligand and the complex respectively, G
O
 is the standard Gibbs free 
energy change, R is the universal gas constant, T is the temperature in Kelvin, G is the 
actual Gibbs free energy change, H is the enthalpy change and S is the entropy change 
for the complex formation. 
 
The unique advantage of ITC is that it is possible to get all these parameters from a single 
experiment if it is done under optimum conditions. 
 
Optimum conditions for ITC are as follows: 
1. The ITC experiments must be done under conditions where the heat change is 
altered from successive injections producing curved thermograms. 
2. The curve in the thermogram is plotted as a function of the macromolecule [M], 
and the equilibrium constant K. 
 




) need to be 













thermogram, but at high enough concentrations to produce measurable heats.   The 




) [1, 5, 6]. 
 
It is exceptionally important that the Cu(II) solutions and the ligand solutions be matched 
with regard to the pH and the concentrations of the buffer [1].   If the two solutions are 
not properly matched, there may be heats of dilution that may accompany the heats of 
formation of the complexes [1, 7-9]. 
 
However, raw data for ITC can be corrected by running three blank experiments [1].   
The first blank experiment can be done by titrating the ligand into the buffer in the 
sample cell.   This will take care of the heats of dilution of the ligand since the ligand will 
be diluted upon titration with Cu(II).   In the second blank titration, Cu(II) solution can be 
titrated into the buffer in the sample cell.  This will take care of the heats of dilution that 
were produced upon titration of the ligand with Cu(II).   The third blank titration can be a 
buffer to buffer titration.   This will be used to zero the ITC instrument [1]. 
 
The corrected heat can be calculated using equation 4.10 and 4.11. 
 
                Qcorr = Qmear – Qdul,lig – Qdil,Cu(II) - Qblank                                                                            (4.10) 
 
Sometimes the ligand may release a proton when titrated with the metal ion.  This proton 
will bind with the buffer and this will be accompanied with the heats of ionization of the 
buffer. [1, 5]  
                     Qcorr = Qmear – (np Hion)                                                                      (4.11) 
 
Where Qcorr is the corrected heat, Qmear is the measured heat,  Qdul,lig is the heat of dilution 
of the ligand solutiion, Qdil,Cu(II) , is the heat of dilution of the copper(II) solution, Qblank is 
the heat of dilution of the blank,  np is the number of protons released by 1mol of the 
ligand upon complexation and Hion is the enthalpy change of protonation of the buffer.   















4.3.1 Preparation of Solutions and Data Handling 
 
The ligand, CuCl2.2H2O and the buffers were purchased from Sigma-Aldrich. They were 
of analytical grade and were used without any further purification.   The Cu(II) solutions 
were prepared from a standard solution of CuCl2.   The ionic strength of the Cu(II) was 
adjusted to 0.15M with NaCl.   The ligand solutions were prepared by dissolving a 
weighed amount of the ligand in distilled deionised water.   Both the ligand and Cu(II) 
solutions were buffered with 20 M buffer (Buffer solutions were prepared by Dave 
Woolley, Division of Chemical Pathology, Clinical Laboratory Sciences, Faculty of 
Health Sciences, University of Cape Town).  The buffers used were NH4 Ac/Acetic acid 
(ammonium acetate/acetic acid buffer) for pH 5.0, MES.TMAH (2-[N-morpholino] 
ethanesulfonic acid) for pH 6.0, MPOS.TMAH (3-[N-morpholinino] propanesulfonic 
acid) for pH 7.0 and EPPS.TMAH (3-[4,(2-hydroxyethyl)-1-piperazinyl] propanesulfonic 
acid) for pH 8.0. 
 
4.3.2 ITC Measurements 
 
The ITC cell was washed with distilled deionised water and rinsed with Cu(II) solution.   
The ITC syringe was rinsed off with the ligand solution before the experiment was run.   
Both the cell and the syringe contents were degassed to get rid of the bubbles before each 
and every titration.  All experiments were done at 25 1
o
C and 700rpm.  The experiments 
were run such that the baseline does not shift and such that the curves do not oscillate.   
This was achieved by adjusting the reference power.   All titrations were run such that a 
1:2 Cu(II)/ligand ratio was achieved, except for the titrations at pH 8 where a 1:3 
Cu(II)/ligand ration was used.   The titrations were done in the pH range 5-8, Cu(II) 

















4.3.3 Experimental Details 
 
A known volume of standard Cu(II) solutions was injected into the sample cell that was 
cleaned and rinsed thoroughly prior to loading.   The sample cell contents were stirred 
continuously until a constant temperature was reached.   The syringe was loaded with the 
ligand solutions.   The syringe was purged twice to remove contaminants and any air 
bubbles that could have been trapped in.   When the sample cell had reached a steady 
temperature of 25
o
C, the ligand was sequentially titrated into the sample cell until the set 




The calibration of the instrument was checked with sodium/EDTA titrations before and 
after every titration.   The pH was measured with a CRISONmicro pH meter equipped 
with a Metrohm electrode.  The results of the sodium/EDTA titrations are as shown in       
Figure 4.2.   Similar results were obtained for the same system under the same conditions 
and molar ratio. 
 
When Ca(II) was titrated with EDTA at pH 6.0 with MOPS buffer at 25
o
C, the most 
predominant species in the Ca(II)/EDTA system were the ML species since N was about 
one.   From literature, the most predominant species in solution at pH 6 are the ML 
species [10-12].   The experimental results therefore match with the literature results.   
However, the experimental value for the equilibrium constant was significantly different 
from the literature value.   This is because ITC can only measure the conditional 
equilibrium constants, and the ITC measurements were done at 0.15M ionic strength with 
NaCl, while the literature values were in 0.1M ionic strength.    
 
Log Kexp = 5.562, the literature values of the log Ks for Ca(II)/EDTA at 0.1M ionic 
strength were 10.65 ( 8) log units [14] and 10.97 log units [13].   This illustrates the 
difference between potentiometry and ITC.   The literature results refer to the formation 













constants and refer to the average binding constant of the species present under the 
conditions of the experiment.   In this case the reaction would be (ignoring the presence 
of the buffer): 
 


















[Ca(II)] = 1.0 mM
Cell Volume = 0.2027mL
[EDTA] = 10mM
18 injections; 18 L first injection and





N 0.886 ±0.00186 Sites
K 3.65E5 ±1.81E4 M
-1

























4.4.1 Determination of Heats of Dilution of Buffers 
 
Titrations of Cu(II) with the buffers were done to check how strongly the buffers bind to 
the  Cu(II) ions.   Buffers that can bind weakly with the metal ion are needed to reduce 
competition with the ligand 
 
At pH 5, Cu(II) was titrated with ammonium acetate/acetic acid buffer and the results are 
presented in Figure 4.3.   The log K for Cu(II)/buffer system at pH 5 was very small thus 
the complex formed between the buffer and Cu(II) at this pH was a weak complex.   A 













horizontal thermogram (y=0) was observed, this shows that there were very poor 
interactions between the buffer and Cu(II) even though the N value was ~1 (with an error 
of 523).   The heats of dilution were too little and the change in entropy was undefined.      
This makes the buffer useful at this pH because it will not compete with the ligand. 
 
 
























N 1.01 ± 523 Sites
K -1.29E3 ± 8.33E5 M-1




















The titrations of Cu(II) with the buffer at pH6 also gave a horizontal thermogram (y=0). 
(Figure 4.4)   The value for G was undefined, the reaction was exothermic and the heats 
of dilution at this pH were too little, close to zero.   The interaction between Cu(II) ions 
and this buffer at this pH is very weak, which makes the buffer useful at this pH because 
it will not compete with the ligand. 
 



























N 2.83E12 ± 2.77E13 Sites
K -2.87E17 ±-- M-1

















Figure 4.5 shows the thermogram that characterizes the Cu(II)/MOPS system.   When 
Cu(II) was titrated with 3-[N-morpholinino] propanesulfonic acid buffer at pH 7.0, heat 
was evolved, unlike the ammonium acetate/acetic acid buffer and the    2-[N-morpholino] 
ethanesulfonic acid buffer.   The equilibrium constant reported by the software is 
meaningless because the heat change is not altered between successive additions (see 
above).   This is also shown by the standard error in the reported K which is 10
5
 larger 
than the K itself.   However, since a significant amount of heat is evolved the data must 
be corrected for this.  The buffer can therefore be used in Cu/glycyl-L-histidine and in 
Cu(II)/glycine titrations, but the stability of the complex relative to the buffer complex 
will be obtained 




























N 2.96 ± 8.01E5 Sites
K 1.52E4 ± 5.58E9 M-1






















Figure 4.6 shows the thermogram that characterizes the Cu(II)/EPPS system.   When 
Cu(II) was titrated with 3-[4,(2-hydroxyethyl)-1-piperazinyl] propanesulfonic acid buffer 
at pH 8.0, heat was evolved, unlike the ammonium acetate/acetic acid buffer and the      
2-[N-morpholino] ethanesulfonic acid buffer.   The equilibrium constant reported by the 
software is meaningless because the heat change is not altered between successive 
additions.   This is also shown by the standard error in the reported K which is 10
4
 larger 
than the K itself.   However, since a significant amount of heat is evolved the data must 
be corrected for this.  The buffer can therefore be used in Cu/glycyl-L-histidine and in 
Cu(II)/glycine titrations, but the stability of the complex relative to the buffer complex 






























N 4.41 ±9.63E4 Sites
K 1.12E4 ± 6.50E9 M-1























4.4.2 Glycine Complexes 
 
The corrected thermodynamic data for Glycine-Cu(II) system at pH 5 is shown in     
Figure 4.7.   At this pH, the reaction was endothermic.    The integrated heat data was fit 
with one site binding model using a package of software that came with the instrument, 
Origin70.    This was done for all Cu(II)/glycine and Cu(II)/glycyl-L-histidine systems 
from pH5-pH8.    
 
The values for N, K, ∆H and ∆S were calculated using Origin70, and are presented in 
Figure 4.7.   A one site model was used and the value for N is approximately one, thus 
the ML species were predominant at this pH.   This model corresponds with the one got 
with potentiometry at the same pH.   However, the ML species gave a small value of   log 
K (Log K = 3.045).   According to published data on Cu(II)/glycine complexes, ML 
species were predominant in solution at pH 5 but at this pH the ML species were 














gradually being converted to ML2 [12].   The speciation graph for potentiometric 
titrations of Cu(II) with glycine have been reported in Section 3.5.3.1, Figure 3.7.   For 
this endothermic reaction (positive ∆H) the formation of ML was non spontaneous since 
∆S was also positive (products were more disordered than reactants), ∆G is therefore 
positive and was calculated as 3.97 Kcal.mol
-1



















18 injections; 1 L first injection and 





N 0.967 ±0.0273 Sites
K 1.11E3 ±64.8 M-1

















Results for Glycine-Cu(II) system at pH 6 are represented in Figure 4.8.   Since S was 
positive the products were more disordered than the reactants.  The copper(II) complexes 
at this pH showed a log K value of 4.009.   The species formed at pH 6 were therefore 
more stable than the species formed at pH 5.   The ML species the value for N is around 
one.   However, glass electrode potentiometry data gave ML2 as the most predominant 
species at this pH [12]. 










































18 injections; 1 L first injection and 





N 1.01 ±0.0236 Sites
K 1.02E4 ±1.72E3 M-1


















At pH 7, the glycine-Cu(II) system gave a very small value of N, N=0.467.   However, 
the standard deviation for N was very little.   Log K at this pH was calculated to be 3.804 
log units.   This was an exothermic reaction, the value for S was positive.   G was 
calculated as -3.32Kcal.mol
-1
.   The thermogram for Cu(II)/Glycine system is shown in 










































36 injections; 1 L first injection and 





N 0.467 ±0.0162 Sites
K 6.37E3 ±628 M
-1
























At pH8, the ML2 species were predominant since the value of N was about 2.   This 
agrees with potentiometric data at pH8.   Moreover the reaction favours the product side 
since H was negative and S was positive.   G was calculated as -3.07Kcal.mol
-1 
using 
equation 4.   The reactants are therefore more disordered than the products.   At this pH, 
log K = 4.238.   This is summarized in Figure 4.9.   The equilibrium constant measured at 
the different pH’s are different because they are conditional constants that are affected by 
competition with H
+
 which changes with pH.   Also the buffers were different at the 




































18 injections; 1 L first injection and 





N 1.77 ±0.0431 Sites
K 1.73E4 ±4.13E3 M-1
























4.4.2 Glycyl-L-Histidine Complexes 
 
At pH 5, N is 1 therefore the ML species were predominant in the                           
Cu(II)/Glycyl-L-Histidine system.   This agrees with the results got from potentiometry. 
[Section 3.5.3.2]   log K = 6.083.   The reaction is fairly exothermic with H 9Kcal/mol.   
The thermogram is shown in Figure 4.10. 
 
From potentiometry, at pH 5, 99.72% of the metal ion was as the ML.   This percentage 
was maintained until the system was at pH 7.01 where the amount started decreasing.   At 





































18 injections; 1 L first injection and 





N 0.945 ±0.00600 Sites
K 1.21E4 ±558 M-1


















At pH 6, N was around one thus the ML species were predominant in solution.       
(Figure 4.11)   However, log K = 5.719 at this pH.   Both H and S are negative.   The 
reactants were therefore more disordered than the products.   G was calculated as           
-12.3.Kcal.mol
-1









































18 injections; 1 L first injection and 





N 0.817 ±0.0476 Sites
K 5.24E5 ±3.87E5 M-1






















At pH7, the value of N is less than 1, therefore at this pH the interaction between the 
ligand and Cu(II) was very poor.   A small N value also indicates the change of 
speciation.  The reaction was spontaneous since ∆H is negative and ∆S is positive.   ∆G 
was calculated as -6.85KCal.mol
-1
.   Results are illustrated in Figure 4.12.   At pH 7 the 











































36 injections; 1 L first injection and 





N 0.517 ±0.00925 Sites
K 1.37E5 ±3.92E4 M-1


















At pH 8, the ML species were predominant in solution since N ≈ 1 M
-1
.   This agrees with 
the potentiometric data.   Log K = 3.914 at this pH.   This was a spontaneous reaction 
since ∆H is negative and ∆S is positive.   ∆G was calculated as -3.17Kcal.mol
-1
.    The 
thermogram for Cu(II)/glycyl-L-histidine system at pH 8 is shown in Figure 4.13. 

































18 injections; 1 L first injection and 





N 1.32 ±0.0351 Sites
K 8.21E3 ±1.51E3 M-1

















4.5 DISCUSSION  
 
The complexes of glycine and copper(II) showed a larger equilibrium constant value at 
pH8 where the ML2 species were predominant in solution.   Therefore the ML2 species 
were more thermodynamically stable than other complexes formed at pH 5-7.   However, 
the reaction gave a large negative value of the conditional ∆G at pH 7.   The spontaneity 
decreased from pH 5-7, at it increased from pH 7-8, therefore the Cu(II)/glycine 
complexes in acidic solutions are not thermodynamically stable but the stability increases 
in basic solutions. 
 
The complexes of Cu(II) and glycyl-L-histidine were more stable, thermodynamically at 
pH 5 log K = 6.083.   However, the production of ML was more spontaneous at pH 6 
where a large negative value of ∆G was observed.   ∆G decreased from pH 5 to pH 6 and 
it increased from pH 6 to pH 8.   However, according to the ITC data, the ML species 
were predominant throughout the study, from pH 5-8.   According to the speciation 













graph, the ML species were predominant from pH 3.84 to pH 8.59 and there was no 
significant change in the amount of ML in solution from pH 4.54 where a percentage of 
97.21 was observed to pH 7.36 where a percentage of 96.29 was observed.   The 
speciation from ITC agrees with the speciation from potentiometry.   The thermodynamic 





















At pH 5 to pH 7, complexes of glycyl-L-histidine and Cu(II) were more stable than the 
complexes of glycine and Cu(II) by 3.038 log units at pH 5, by 1.710 log units at pH 6 
and by 1.333 log units at pH 7.    At pH 8, the complexes of glycine and Cu(II) were 
more stable than the complexes of  glycyl-L-histidine by 0.324 log units.   The ML 
species in a glycyl-L-histidine system were therefore more stable than the ML species of 


























































glycine, and the ML2 species of glycine (dominant in solution at pH 8) were more stable 
than the ML species (dominant in solution from pH 5 to pH 6) at pH 8. 
 
For the first three titrations, Cu(II)/glycine pH 5; Cu(II)/glycyl-L-histidine pH 5 and 
Cu(II)/glycine pH 6, the total heats of binding were positive (endothermic reaction).   
Glycyl-L-histidine system (pH 5) being the most endothermic followed by the glycine 
system at pH 5 then followed by the glycine system at pH 6.   Titrations of Cu(II) with 
glycyl-L-histidine at pH 6 to pH 8 were exothermic with the titrations at pH 6 being the 
most exothermic, followed by  pH 7, followed by pH 8.   Titrations of Cu(II) with glycine 































 at pH 8.   S for the titrations of 




Ammonium acetate/acetic acid buffer was suitable for the ITC measurements at pH 5.0, 
2-[N-morpholino] ethanesulfonic acid buffer was suitable to be used at pH 6.0, 3-[N-
morpholinino] propanesulfonic acid buffer was suitable to be used at pH 7.0 and it was 
convenient to use 3-[4,(2-hydroxyethyl)-1-piperazinyl] propanesulfonic acid buffer at pH 
8.0. 
 
The speciation from ITC the results agreed with that of potentiometry.   The ML species 
of Cu(II) and glycine formed at lower pH’s, and the ML2 formed at higher pH’s.   From 
pH 5 to pH 8 the most predominant species of the Cu(II)-glycyl-L-histidine system was 
ML, however different species began to form at pH 7 where N dropped to 0.517.   In the 













New species began to form at pH 7 where N dropped to 4.67.   At pH 8, ML2 was the 
most predominant species in solution. 
 
ITC results also showed that ML2 of Cu(II) and glycyl-L-histidine were more stable than 
ML of the same system.   The interaction between Cu(II) and glycine at pH 5 and pH 6 
was endothermic, and the interaction at pH 7 and pH 8 gave out heat.   The interaction 
between Cu(II) and glycyl-L-histidine at pH 5 was endothermic and it was exothermic at 
pH 6-7.   Reactions of Cu(II) and glycyl-L-histidine were more spontaneous than the 
reactions of Cu(II) and glycine at the same pH, the formation of ML at pH 8 being the 
most spontaneous reaction of all the complex formation reaction of Cu(II) and the two 
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5.  SPECTROSCOPY AND ANCILLARY 
STUDIES 
5.1 ULTRAVIOLET-VISIBLE (UV-Vis) SPECTROPHOTOMETRY 
5.1.1 Introduction 
 
Coloured species absorb light in the UV-Vis region [1, 2].   The amount of radiation 
absorbed can be measured in several ways;  
i. The absorbance (A),  
ii. The transmittance (T) and  
iii. The percentage transmittance (% T)  
 
The absorbance of the solution depends on the concentration of the species solution, the 
path length of the sample cell and the absorbtivity of the species [2, 3].   This can be 
expressed by Beer’s Law; 
 
                     A = bc                                                                                                      (5.1) 
Where; 
 
A is the absorbance of the species,  is the absorbtivity (molar extinction coefficient), b is 
the path length of the sample cell and c is the concentration of the absorbing species. 
When a beam of monochromatic radiation is directed into a coloured sample solution, 
some of the light is absorbed by the solution and some of it is radiated as shown in   







 Figure 5.1 shows a single beam of light of radiation power Po going through the 
sample cell of path length b and the single beam of light of radiation power P 
leaving the sample cell 
Po 
P 















The absorbance can be expressed in terms of Po and P as in Equation 5.2. 
 
                     A = Log     Po                                                                                             (5.2) 
                                       P 
 
 
Transmittance (T), which is described as the fraction of incident light that passes through 
a sample at a specified wavelength can be expressed in terms of Po and P as; 
 
 
                     T =       P                                                                                                    (5.3) 




                     T
-1
 =    Po                                                                                                   (5.4) 




Putting Equation 5.4 into equation 5.2 yields; 
 
 
                     A = Log T
-1
                                                                                                (5.5) 
 
 
The absorption of radiation in the UV-Vis region corresponds with the excitation of 
electrons [3, 4].   In coordination chemistry, electrons that engage in bonding are mainly 
the d electrons.    Most transition metal (of which Cu(II) is one) complexes have colour 
and they absorb light in the UV-Vis region because of the energy gained when electrons 
are transformed from a lower energy level to the higher energy level.   The difference 
between energy levels corresponds with the wavelength of the absorbed light and is often 













In this study, UV-Vis spectrophotometry was used to examine the structure of complexes 
in solution. 
From spectrophotometric data, the models that were observed with potentiometry were 
compared with the UV-Vis spectra obtained at difference pH’s.   However, the stability 
constants were not re-calculated with UV-Vis spectrophotometry since most complexes 
contain broad overlapping absorption bands which make the evaluation of the stability 
constants not as precise as in potentiometry.   Instead the data were used to infer 
something about the structure of the species in solution.  
 
5.1.2     Experimental 
5.1.2.1      Preparation of Solutions 
 
1:2 Cu(II)/glycyl-L-histidine solutions were prepared in distilled deionized water.   These 
solutions were of known volume and known concentration.    The complex solutions 
were titrated with standard NaOH solution and standard HCl solution to adjust the pH 
from 3.71-11.55 in about 1.0 increments.   The pH was measured with a CRISONmicro 
pH meter equipped with a Metrohn electrode.   The volume of acid/base added was noted 
and the concentrations of the Cu(II)/ligand recalculated. 
 
5.1.2.2      UV-Vis Measurements 
 
A clean sample cell (curvet) was rinsed with distilled water.   The UV-Vis machine was 
zeroed with distilled deionized water.   The UV-Vis machine (Hewlett Packard 8452A 
Diode Array Spectrophotometer) was set at 350nm-820nm.   Absorbances of the samples 
were measured from pH 3.71 to pH 11.55.   The curvet was rinsed with the sample 
solutions before every measurement. 
 
5.1.2.3      Data Handling 
Since the speciation of the solution changes with pH it is always not possible to measure 
the spectrum of an individual species directly.   Instead the spectra at different pH values 












home written computer program.   This program requires the concentration of each and 
every species in each solution and then calculates the molar extinction coefficients at 
different wavelengths.   This is then the spectra of each species.   UV_SPECTRA.EXE 
was used to calculate the molar extinction coefficients of Cu(II) and the complexes ML, 
MLH-1, MLH-2 and MLH-3 respectively.  The agreement between the calculated and the 
observed absorbances (the residual absorbance) was calculated.   The residual absorbance 
was calculated using Equation 5.6 
 








 is the observed absorbance and A
c
 is the calculated absorbance. 
 
5.1.3      Results 
 
When the pH of the Cu(II)/glycyl-L-histidine system was increased from pH 3.71 to pH 
8.91, the color of the complexes changed gradually from blue to a faint purple colour.   
This shows that there was a different species formed at pH 8.17.   When the pH was 
changed from 8.17 to pH 11.55, the colour of the solution changed from a faint purple 
colour to a deep purple colour.   This indicates the formation of the new species at pH 
11.55.    
 
Figure 5.2 shows a plot of absorbance as a function of wavelength for the Cu(II)/glycyl-
L-histidine systems from pH 3.71 to pH 11.55.   From Figure 5.2, as the pH increased, 
the maximum wavelength shifted towards shorter wavelength.   This indicates the 
presence of different species in solution at different pH’s.   There is no isobestic point as 







































Figure 5.3 shows the molar extinction coefficients as a function of wavelength for the 
species Cu(II), ML, MLH-1, MLH-2 and MLH-3 respectively.   Since the program 
calculates the extinction coefficients at each wavelength independently, the fact that 
smooth curves are obtained for each species lends confidence to the model and 
equilibrium constants obtained from potentiometric study.   From the spectra, the 
wavelengths of maximum wavelength ( max) can be estimated.   These results are given in 








 which compares well with 











Figure 5.2: Raw UV-Vis data; absorbance of Cu(II)/glycyl-L-histidine as a function 
of wavelength from 400nm to 800nm UV-Vis region. 
























pH3.71 pH3.71 pH4.02 pH4.02 pH4.22 pH4.22 pH5.10
pH5.10 pH6.34 pH6.34 pH7.06 pH7.06 pH8.19 pH8.19






































) max (nm) 
ML 17.22 600 
MLH-1 18.56 565 
MLH-2 0.67 554 
MLH-3 18.01 550 
[Cu(H2O)4]
2+
 1.48 800+ 
 
 
The interpretation of the spectra was made using Billo’s method (updated by Presenti and 
co-workers) [6].   The λmax of species can be estimated using Equation 5.7 
 
                          λmax = 10
3/∑niνi                                                                                    (5.7) 
 
Table 5.2; Molar extinction coefficients and max for Cu(II)/glycyl-L-histidine systems a varying pHs 
Figure 5.3: ; Molar extinction coefficients a function of max for Cu(II)/glycyl-L-histidine systems 
at varying pHs 
























































Where ni is the number of equatorial donor group and νi is the ligand field of the 
complex.   The νi values for corresponding donor groups are shown in Table 5.1. 
 
 
Electron Donor Group νi (µm
-1
) 
Carboxylate oxygen 0.353±0.008 
Water oxygen 0.296±0.006 
Hydroxide oxygen 0.39±0.03 





None of the species absorbed UV-Vis light in the range 240-300nm therefore Cu(II) did 
not bind on the carboxylate oxygen of the ligand because none of the λmax’s corresponded 
to νi  of 0.353µm
-1
 .   Glycyl-L-histidine thus has three possible binding sites, the amide 
nitrogen, one of the two imidazole nitrogens and the terminal NH2 group.   The possible 
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5.1.5 Conclusion  
 
The structures “a”, “b” “c” and “d” are possible structures for ML.   However, the 
complex is highly unlikely to have existed in the “a” form since the pKa of the COOH for 
this ligand was 2.29.   Structures “b” is more appropriate than “c” because there is more 
electron cloud on the protonated imidazole N-atom of Structure “b” than there is in the 
imidazole N-atom of Structure “c”.   The terminal NH2 was deprotonated at high pH (pKa 
8.34) therefore ML is highly unlikely to exist in “d” form.   The most possible structure 
of ML is therefore structure “b”. 
 
The most possible structures for MHL-1 are “e” and “f”.   MHL-1 forms at high pH 
(beyond 8.34 which is the pKa of the terminal NH2 group thus MHL-1 is highly likely to 






















5.2      NMR SPECTROSCOPY 
5.2.1 Introduction 
 
Unlike in ultraviolet-visible spectroscopy, in nuclear magnetic resonance spectroscopy 
(NMR) the absorption of radiation is not by the d electrons but it is by the nuclei that are 
exposed to a magnetic field [5, 6, 7].    
 
In this study, 
1
H NMR spectroscopy was used to investigate the sequence of protonation 
of the ligand; and to examine the sequence of complexation of glycyl-L-histidine with 
Cu(II).   Upon protonation, the NMR signals of the ligand close to the basic site are 
expected to shift.   The signals are expected to shift to low to high field as the amount of 
acid is decreased [8, 9]. 
 
Moreover, since Cu(II) has an electronic configuration of [Ar] 3d
9
, Cu(II) compounds are 
paramagnetic [10, 11].   The NMR signals of the ligand are expected to broaden when 
Cu(II) binds to the ligand.   The broadness of the resonance is dependent on the 
concentration of the metal ion and the internuclear distance between the nucleus and the 
metal ion.   By monitoring the differential broadening, it is possible to obtain information 
about the site of coordination. 
 
5.2.2 Experimental 
5.2.2.1 Preparation of Solutions 
 
All solutions were prepared in D2O.   The pD of the solutions was adjusted sequentially 
from pD 2 to pD 11 using 0.01M NaOD and 0.001M DCl solutions.   The pH was 
measured with CRISONmicro pH meter equipped with Metrohm electrode.   The           
1
H NMR measurements were done on a VXR 300 MHz spectrometer.   Tertiary butyl 














5.2.2.2 NMR Measurements 
 
For the protonation of the ligand, the pH of the ligand solution was adjusted to pH 3.85, 
pH 5.77, pH 6.96, pH 7.46, pH 8.08, pH 9.29, and pH 10.95 with DCl/NaOD.   The 
spectra at each of these pH’s was measured.   For the complex formation titrations, Cu(II) 
solutions were titrated into the ligand solution.   For some titrations, the pH was kept 
constant and the amount of Cu(II) was varied, while others, the amount of Cu(II) was 
kept constant and the pH was varied as shown in Table 5.3.   The solutions were put in 





Solutions pH [Cu(II)]   / mM 
1 7.42 10 
2 7.42 20 
3 7.42 30 
4 7.42 60 
5 7.42 110 
6 8.05 110 
7 10.09 110 
 
 
Since DCl was used to adjust the pH instead of HCl, the pH measurements were therefore 
in pD units.   pD was converted to pH by Equation 5.8.    
 
                     pH = pD – 0.4                                                                                            (5.8) 
 
The t-butyl alcohol was used as an internal reference.   The change in chemical shift was 
plotted as a function of pH as in Figure 5.6. 
 
Table 5.3; A table showing the pH and amount (in mM) of Cu(II) titrated into the ligand solutions for 
the 
1



































The results for the ligand titration are shown in Figure 5.5.   The assignments for the 
spectra are indicated and follow the numbering in Figure 5.4.   The signals “a” and “b” 
were the first to shift from low to high field.   The shifting of signals “a” and “b” was due 
to the deprotonation of one of the N-atoms of the imidazole group.   These signals started 
shifting at a very low pH and were still shifting at pH 9.    
 
Signal “d” started to shift from pH 8.08.   A significant change in the position of the “d” 
signal was observed at a higher pH.   This was due to the deprotonation of the peripheral 
amine nitrogen.   The sequence of protonation of     glycyl-L-histidine was in this 
manner; the pKa of 2.29 corresponded to the protonation of the carboxylic group, the 
protonation of the imidazole nitrogens was at pKa = 6.61 and the terminal NH2 
corresponded to pKa = 8.34. 
 
Figure 5.4: The structure of the ligand showing the protons that 
can be observed by 
1
H NMR spectroscopy.   The letters “a” to “e” 
















The change in the position of the signals was plotted as a function of pH as shown in 
Figure 5.6.   The graphs a, b, c and e in Figure 5.6 show the pKa of around 6.6 and graph 
e shows a pKa of around 8.3.   These were in good agreement with the pKas of the 
imidazole nitrogen (pKa = 6.61) and pKa of the terminal NH2 group (pKa = 8.34) 
calculated from glass electrode potentiometry. [Section 3.5.2; Table 3.2]   the other pKa 














H NMR for the protonation of glycyl-L-histidine 












Change in Chemical Shift for 
1
H  N M R for Protonation of Glycyl-L-






















   
   
   
   
   
   










5.2.3.2 Complexation of the Ligand with Cu(II) 
 
The spectrum for the complexation of the ligand with Cu(II) is shown in Figure 5.7.   
When the pH (pH 7.42) was kept constant and the amount of Cu(II) titrated into the 
ligand  solution, the signals did not shift significantly but they broadened extensively, 
with signals “a” and “b” showing the most observable changes.   The most predominant 
species at pH 7.42 is the ML species and this indicates that the imidazole must be 
coordinating to the Cu(II).   Since “d” is not broadened, the Cu(II) is not coordinated to 
the terminal amine. 
  
 
The signals broadened and shifted significantly when the pH was varied and the amount 
of Cu(II) was kept constant.   The shifting is due to the pH change and the broadening is 
due to the Cu(II).   At pH 8.05, there are two species in solution, the ML and the MLH-1.   












At pH 10.09, the most predominant species is the MLH-1.   The most affected signals 
were signal “a”, signal “b” and signal “d”.   The copper ion was therefore bonded to one 










The pH for the complex formation titrations was not varied much therefore a similar 




The three protonation constants of glycyl-L-histidine were assigned to the carboxyl 
group, the imidazole nitrogens and the terminal NH2 group respectively.   The carboxyl 
group was protonated at very low pH, followed by the imidazole nitrogens.   The terminal 
NH2 group was protonated in very basic solutions. 













H NMR for the complexation of glycyl-L-histidine with Cu(II).  
Spectrum 1   (pH=7.42;   [Cu(II)] = 10mM) 
Spectrum 2   (pH=7.42;   [Cu(II)] = 20mM) 
Spectrum 3   (pH=7.42;   [Cu(II)] = 30mM) 
Spectrum 4   (pH=7.42;   [Cu(II)] = 60mM) 
Spectrum 5   (pH=7.42;   [Cu(II)] = 110mM) 
Spectrum 6   (pH=8.05;   [Cu(II)] = 110mM) 















Glycyl-L-histidine had three binding sites for Cu(II); one of the imidazole nitrogens, the 
amide nitrogen and the nitrogen of the terminal NH2 group.   Complexation began on the 
imidazole nitrogen and the amide nitrogen, at pH 7.42.   Cu(II) bonded to the nitrogen of 
the terminal NH2 group at higher pH. 
 
5.3 BLOOD PLASMA MODEL 
5.3.1 Introduction 
 
The speciation of glycyl-L-histidine and Cu(II) in blood plasma was studied with 
ECCLES (Evaluation of Constituent Concentrations in Large Equilibrium Systems) [12].   
ECCLES is a database that uses cumulative stability constants to predict clinical 
properties of species in blood plasma.   The program has a preprocessor, MIX, which 
estimates the stability constants (log s) of mixed complexes that are predominant in 
blood plasma [13].   
 
In addition, ECCLES also gives the plasma mobilizing indices (p.m.i).   By definition 
p.m.i is the ratio of the total concentration of low molecular weight metal complex 
species in the presence of the drug to that of normal plasma.   The plasma mobilizing 
index gives extend to which the ligand (drug) can move the metal ion in blood plasma 
from a protein bound form to the low molecular weight form.   The greater the value the 




Table 5.4 gives the speciation of glycyl-L-histidine in blood plasma.   The LH species 
was the most predominant species in blood plasma followed by LH2.   About 79.4 % of 
the glycyl-L-histidine species was in LH form, and about 11.5 % was in LH2 form.   The 




























LH - 7.94E+00 79.4 
LH2 - 1.15E+00 11.5 
ML Zn(II) 9.76E-06 - 
LH3 - 9.20E-06 - 
MLH Zn(II) 2.28E-06 - 
M2L2 Zn(II) 4.02E-07 - 
M2L2H-1 Zn(II) 2.59E-07 - 
ML2 Zn(II) 1.47E-08 - 
ML Cu(II) 1.31E-11 - 
MLH-1 Cu(II) 5.53E-13 - 
MLH-1 Ni(II) 4.44E-13 - 
ML Ni(II) 3.09E-13 - 
MLH Ni(II) 2.12E-14 - 
MLH-2 Cu(II) 5.16E-18 - 
MLH-3 Cu(II) 9.47E-21 - 
ML2 Ni(II) 2.94E-22 - 
ML2H-1 Ni(II) 1.28E-26 - 
 
 
This means that even though, the Cu(II) complex is more stable than the Zn(II) complex, 
Cu(II) is not able to compete with Zn(II) in vivo.   This is because the Zn(II) 
concentration is so much higher than the Cu(II) concentration.   Also glycyl-L-histidine is 
not able to significantly mobilize Cu(II).   It requires a ligand concentration of 0.1M in 
order to increase the low molecular mass fraction of Cu(II) 10 fold.   This concentration 
is unreasonably high.   For these two reasons glycyl-L-histidine is unlikely to be of value 




Table 5.4: A table showing the distribution of protonated and the complex form glycyl-L-histidine 
species in blood plasma.   The concentration were put in descending order.   The initial concentration 



























The results were compared to data that was reported earlier [14, 15].   PrDPr which was 
reported to mobilize Cu(II) more than Zn(II); TRIEN which was reported to mobilize 
Cu(II) more than other ligands: DTPA, EDDA, TTDA and DTDA (structures Appendix 
2).   The mobilizing abilities of PrDPr and TRIEN were better than the mobilizing index 
of glycyl-L-histidine as shown in Figure 5.9.   The gap between Cu(II)/glycyl-L-histidine 
and Cu(II)/PrDPr was huge.   The ability of TRIEN to mobilize Cu(II) in blood plasma 










Figure 5.8: Log10 p.m.i as a function of log [L] for the complexes of glycyl-L-histidine 
























































Glycyl-L-histidine existed mainly existed as LH in blood plasma.   Under physiological 
conditions, very little metal complexes of glycyl-L-histidine were found.   This means 
that glycyl-L-histidine would mobilize Ni(II) in blood plasma before if mobilizes Cu(II)   
This is not desirable.   The p.m.i of Cu(II), Ni(II) and Zn(II) complexes with glycyl-L-
histidine was in the sequence; 
 
Ni(II) < Cu(II)< Zn(II) 
 
Moreover, when the glycyl-L-histidine was compared to DTPA, EDDA, TTDA and 
DTDA it had very low p.m.i therefore it is not the suitable to be used as an anti-
inflammatory agent. 
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6. GENERAL DISCUSSIONS AND 
CONCLUSIONS 
 
The stability constants of the ligand, glycyl-L-histidine, were compared to the stability 
constants of glycine since glycyl-L-histidine has a glycine terminal.   The stability 
constants of the ligand with Cu(II) were also compared to the stability constants of 
Ni(II)/glycyl-L-histidine and Zn(II)/glycyl-L-histidine complexes.   
 
The values of the stability constants for all these systems were in agreement with the 
literature values [1-7].    
 
The equilibrium constant for the copper(II) complexes of glycine and copper(II) 
complexes of glycyl-L-histidine were also investigated with isothermal titration 
calorimetry.   This method was not as accurate as glass electrode potentiometry since the 
latter did not involve buffers; the change in potential described the interaction between 
the metal ion and the ligand, while the signal in isothermal titration calorimetry described 
the interaction between the metal ion, the buffer and the ligand.    
 
Moreover, since ITC could not be used for sequential titrations of the metal ion solution 
with the ligand solution, the speciation graph for the metal/ligand system could not be 
constructed from pH 2 to pH 11 as in glass electrode potentiometry.   ITC measurements 
could not be done at very low pHs and high pHs.   Very acidic solutions could corrode 
the ITC sample cell and Cu(II) precipitated out in basic solutions (pH ≥ 9).    
 
The method was used from pH 5 to pH 8, and in this pH range, the buffers used were 
NH4 Ac/Acetic acid (ammonium acetate/acetic acid buffer) for pH 5.0, MES.TMAH    
(2-[N-morpholino] ethanesulfonic acid) for pH 6.0, MPOS.TMAH (3-[N-morpholinino] 
propanesulfonic acid) for pH 7.0 and EPPS.TMAH (3-[4,(2-hydroxyethyl)-1-piperazinyl] 













The heats of dilution of these buffers were measured before the metal ion/ligand titrations 
could be made.   This was done to check if the heats of dilution are too high to mask the 
real heats of binding of the ligand and the metal ion.   The heats of dilution for all the 
four buffers were negligible.  
 
The ITC machine was calibrated with a simple system of Ca(II)/EDTA.   The ITC results 
for this system were in good agreement with the ITC measurements for same system that 
have been reported before [8]. 
 
According to the potentiometric studies ML species of Cu(II)/glycyl-L-histidine and 
Cu(II)/glycine were predominant at pH 5, and from pH 6-8 the ML2 species of 
Cu(II)/glycine system was predominant in solution.   When Cu(II) was titrated with 
glycyl-L-histidine at pH 5 in ammonium acetate/acetic acid buffer, the most predominant 
species were ML.   This was an endothermic reaction and conditional equilibrium 
constant was 4.083.   When Cu(II) was titrated with glycine at the same pH, the 
conditional equilibrium constant was 3.045.   This was an endothermic reaction and ML 
species were predominant in solution.   The Cu(II)/glycine complexes at this pH were 
less stable than the Cu(II)/glycyl-L-histidine complexes at the same pH. 
 
When Cu(II) was titrated with glycyl-L-histidine at pH 6 in MES buffer, the most 
predominant species was ML.   The conditional equilibrium constant for this system at 
pH 6 was 5.719.   The ML species was predominant is solution since N ≈ 1.   This was a 
spontaneous exothermic reaction since ∆ H is negative and ∆S is positive.   When Cu(II) 
was titrated with glycine at the same pH, the conditional equilibrium constant was 4.009.   
This was an endothermic reaction and ML species was predominant in solution.   The 
Cu(II)/glycine complexes at this pH was less stable than the Cu(II)/glycyl-L-histidine 
complexes at the same pH. 
 
At pH 7, in Cu(II)/glycyl-L-histidine system N was less than 1.   This shows that there 
was a different species formed at this pH.   At pH 8, the N value was 1.32.   The reaction 












positive for both reactions, thus the forward reaction at this pHs was favoured.   Log K 
for the pH 7 titration was 5.137 and log K for the pH 8 titration was 3,914. 
 
At pH 7, in Cu(II)/glycine system N = 0.467.   This shows that there was a different 
species formed at this pH.   At pH 8, N ≈ 2.   ML2 species were predominant at this pH.   
The reaction at pH 7 and pH 8 for the same system was exothermic.   The change in 
entropy was positive for both reactions, thus the forward reaction at this pHs was 
favoured.   Log K for the pH 7 titration was 3.804 and log K for the pH 8 titration was 
4.238. 
 
UV-Vis spectrophotometry and 1H NMR were used to predict the structure of complexes 
of glycyl-L-histidine with Cu(II).   The visible spectra obtained for the different 
Cu(II)/Glycyl-L-histidine in solution are typical of Cu(II) complexes in a tetragonally 
distorted, octahedral environment.   Only one broad band is observed for each species and 
this can be assigned to the d-d transition.   The molar extinction coefficients are also 
typical of Cu(II) complexes and reflect the distortion of the metal-ion environment. 
 
The energy of the transition is dependent on the metal-ion environment.   Billo, Presenti 
and co-workers [9, 10] have devised an empirical method of estimating λmax for different 
coordination spheres.   These are shown in Figure 5.3.   These values were compared to 
the values calculated using Equation 6.1. 
 
                          λmax = 10
3/∑niνi                                                                                     (6.1) 
 
Where λmax is the maximum wavelength, ni is the number of equatorial donor group and 
νi is the ligand field of the complex.   The measured values agree with the values 




H NMR, deprotonation of the ligand commenced on the carboxylate group, 
followed by the imidazole nitrogen followed by the N-atom of the NH2 terminal.   












were observed with 
1
H NMR because deprotonation of the carboxylate group occurred at 
very low pH’s.   The possible structure of the ligand are shown as LH3 for the ligand that 
has three dissociable protons, LH2 for the ligand that has two dissociable protons, LH for 
the ligand that has one dissociable proton and L for the neutral form of the ligand.   
However, the LH3 form of the ligand was not observed with 
1
H NMR since deprotonation 
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At pH 3.85 and pH 5.77, the ligand was in LH2 form; at pH 6.96, pH 7.48 and pH8.08, 
the ligand was in LH form and at pH 9.29 and pH 10.95, the ligand was in its neutral 
form, L.   The structures of glycine are show below. 
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       LH2                                          LH                             L 
 
At pH < 2 to pH 4.20, glycine exists as LH2, at 2 < pH < 11, the ligand there was LH in 












For complex formation titrations, Cu(II) bonded to the imidazole nitrogens  and on the  
N-atom of the terminal NH2 group since the affected signals were “a”, “b” and “d”.   
When the pH was kept constant (pH 7.42), the signals did not shift significantly but they 
broadened as the amount of Cu(II) ions was increased in solution.   When the amount of 
Cu(II) ions in solution was kept constant ([Cu(II)] = 110mM]), the 
1
H NMR signals did 
not broaden significantly but they shifted significantly.   This shows that different species 
were formed at different pH’s. 
 
At pH 7.42, the most predominant species were the ML species.   The most possible 
structures of the complex at this pH are structures “a” and “b”.   From potentiometry    
(Q-bar plot), the ligand lost two protons upon complexation with the ligand.   This makes 
Structure “b” more suitable for ML than Structure “a”.   Moreover, from the 
1
H NMR, 
the signal for the “d” protons (Figure 5.4) was not shifting at pH 7.42 where the ML 
species were predominant. 
 
 At pH 8.05, the “d” signal shifted from high field to low field.   At this pH, the central 
metal ion was bonded to the electron donor atom of the terminal NH2 group.    
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Combining UV-Vis and 
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To test whether the ligand can increase the low molecular weight copper(II) complexes in 
blood plasma, the cumulative equilibrium constant of the ligand and of the Cu(II)/glycy-
L-histidine complexes were put in a computer blood plasma model.   ECCLES was used 
to evaluate the capacity to which the ligand can increase concentration low molecular 
weight Cu(II) complexes in blood plasma.   From ECCLES output, most of the ligand in 
blood plasma existed in LH and LH2 form.   The ligand was not able o compete with 
endogenous blood plasma ligands.   Moreover, the complex form of the ligand was 
mostly Zn(II) not Cu(II).   The ligand therefore has a higher capacity of mobilizing Zn(II) 
than it does for Cu(II).   This is because in vivo concentration of Zn(II)  is much higher 
than does it for Cu(II).   However, the ligand mobilized Cu(II) in blood plasma than it 
mobilized Ni(II), and the difference between the two mobilizing capacities was not 
negligible.   PrDPr has been reported to mobilize Cu(II) than Zn(II) [11].     
 
When data for this ligand with Cu(II) was compared to that of Cu(II) with                
glycyl-L-histidine, PrDPr had a higher mobilizing capacity the latter.   Moreover, when 
Cu(II)  complexes of glycyl-L-histidine were compared to Cu(II) of TRIEN, which has 
been reported to have a higher mobilizing capacity for Cu(II) in blood plasma [12].         
Glycyl-L-histidine had a lower mobilizing capacity than TRIEN.   The stability constants 
































From potentiometric data, TRIEN formed very stable complexes with Cu(II) compared to 
glycine and PrDPr.   However, the ML species of Cu(II) complexes with                 
glycyl-L-histidine were more stable than the ML species of PrDPr with Cu(II).   
However, the MLH-1 and MLH-2 of PrDPr were more stable than the MLH-1 and MLH-2 
of   glycyl-L-histidine and it is these species which are formed at physiological pH.   In 
















been successfully measured using glass electrode potentiometry.   These results were 
compared to the stability of the glycine complexes.   In silica modeling of blood plasma 
speciation, using the determined stability constants showed that the ligand was not able to 
effectively mobilize Cu(II) in vivo.   This is both because the complexes are not stable 
enough to compete against endogenous ligands and also because it is not sufficiently 
selective for C(II) over Zn(II).   Since Zn(II) is present in blood plasma at a much higher 
concentration than Cu(II), the Zn(II) complex preferential forms. 







































Spectroscopy was used to study the structure of the different species in solution.   From 
these results it was postulated that in the ML species the metal coordinates to one of the 
imidazole N-atoms nitrogens and the amide nitrogen. 
 
The final conclusion is that glycyl-L-histidine is not suitable as a Cu(II) based anti-
inflammatory drug.   The inability of the ligand to mobilize Cu(II) in vivo is perhaps 
surprising since it is so similar to HSA, the endogenous copper transport protein.   These 
results need to be compared with the terminal amino acid sequence of HSA. 
 
6.1 FUTURE WORK  
 
Ligands with two acetylhistidine moieties will be used, one with a cage and the other 
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Appendix 1 (COMPUTER MODEL OF BLOOD PLASMA) 
BDP0 
GLYH  
PLED Glycyl-L-histidine(Ligand under study) 
EHP4  
EDD5 glycine,N,N'-1,2-ethanediylbis-N-(2-hydroxyphenyl0) 
HYD1 ethylene dinitrilo-N,N'-dinitrilo-N,N'-diacethylhdroxamic-N,N'-diacetic acid 
HBD4 ACETYL-HYDROXAMIC ACID 
CAT2 HBED 
TRN2 CATECHOL 
TTH6 TIRON-1,2-DIHYDROXYBENZENE-3,5-DISULFONIC ACID 
PMG3 TRIEN-HEXA-ACETIC ACID 
DDD1 N-PHOSPHONOMETHYLGLYCINE 
































































BAL2 PEPTIDE MIMICKING ALBUMIN (N-METHYL-DIGLYCYLHISTIDINE 






CIQ1 ACETYLSALICYLIC ACID 
FEN0 CARBOXY-ISOQUINOLINE 
ATH1 FENAMOLE 














DMS4 2,3-DIMERCAPTOPROPANE SULPHONIC ACID 
CAP2 2,3-DIMERCAPTOSUCCINIC ACID 
TTD2 CAPTOPRIL 
DTD2 TTDA (3,6,9,12-TETRAAZATETRADECANEDIOIC ACID) 




HED3 PAMIDRONIC ACID 
HID2 HEDTA 


































F -1  
CARB   
TFRN PROTEIN SIMULATOR-CARBOXYLATE FUNCTIONS 
ALBM PROTEIN SIMULATOR-TRASNSFERRIN 



























































TTDA: 3,6,9,12-TETRA-AZATETRADECANEDIONIC ACID 
 
Appendix 2 (STRUCTURES OF DTPA, DTDA and TTDA) 
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